Professor  Francesco Paolucci

Professor Francesco Paolucci

Professor

Newcastle Business School (Economics)

Affordable healthcare at what cost?

Professor Francesco Paolucci is an internationally acclaimed scholar and advisor using research to enhance policy in economics and public health, resulting in more equitable and efficient healthcare for communities worldwide.

Professor Francesco Paolucci

Healthcare systems are complex by design; is it better to pay top dollar for private health insurance, or does it make more sense to rely on public healthcare instead? Is the current approach to financing Australian healthcare really the best option for Australians, or is there an alternative that would work better?

Attempting to answer these and other questions, Professor Francesco Paolucci has spent two decades analysing global healthcare systems—including working with governments, public and private agencies and industry globally—with the aim of creating more accessible and efficient care for patients as well as greater efficiency and value for stakeholders worldwide.

“My work has multiple high-level goals,” explains Professor Paolucci. “Firstly, it aims to help address healthcare system inefficiencies and inequalities in Australia and overseas. It also supports government and industry to articulate structural reforms and design policies to address access, affordability, universal coverage to improve health outcomes.”

“Ultimately to improve and reward performance in healthcare systems we need a multi-skilled workforce. Hence my work has always focused on developing educational and training programs in these areas. Like our new suite of health economics management and policy programs”.

To achieve these goals, Francesco works to unpack complex issues in international health policy, such as “affordability of healthcare”, “fairness of access” and “the efficiency of healthcare systems”. In Australia, tackling these larger issues involves examinations of current healthcare financing arrangements and the complex relationships between private health insurance and Medicare, the nation’s publicly funded universal healthcare system—with the purpose of informing improved policy solutions.

Francesco also currently serves as the Australian representative at the Risk Adjustment Network (RAN).This global network was founded by economists and practitioners from top institutions both public and private  to endorse an international exchange of knowledge to advance design and implementation of policies that regulated healthcare financing and insurance worldwide, specifically risk adjustment and risk equalisation, and risk sharing scheme, which helps to ensure insurance premiums remain fair and reasonable, and protects disadvantaged community groups from insurance discrimination. The RAN also helps communicate this scientific knowledge to governments, so that evidence can guide future health insurance policies.

“We need industry and government to understand the value of appropriate risk classification and data sharing in healthcare and the importance of health data analytics in bringing about evidence-based change that benefits patients and people—especially for high-risk and low-income groups.”

“Ultimately, we want to improve how health systems respond to the needs of the vulnerable, in regard to effectiveness, equitably and affordably.”

Leading global health reform

Professor Paolucci’s work is not confined to Australia, either; he has worked internationally, from his current positions as Professor of Health Economics and Policy with the University of Newcastle and the University of Bologna, Italy, to his former role as Chief Economic Advisor to the Minister of Health in Chile. In this significant advisory role with the Government of Chile, Francesco led the design of the country’s new Health Insurance Act (2018). His team analysed the economic, actuarial and econometric costs of the new universal health plan and looked at government and regulatory tools that could oversee and monitor the new marketplace.

This is also not the first time his work has led to change:

“My work for governments and industry has translated into policies and reforms which have transformed healthcare systems by making them more accessible and efficient in a number of countries.”

The international network that Francesco has developed gives him the ability to conduct a wide variety of research in other national healthcare contexts—including in places like, China, Italy, the Netherlands and Qatar—giving his work an international perspective that can provide impactful lessons for policymakers both at home and abroad.  Driven by his understanding of the power of international knowledge transfer to improve health policy, Francesco created the University of Newcastle’s very own health economics and policy group: Value in Health Economics and Policy (VheP).

The creation of VheP also proved to be very timely; when the Covid-19 pandemic began, Francesco had already ensured that the group was ready to respond. Co-ordinating and editing a collaboration of over 80 researchers from around the world, led to the creation of a special issue for the journal Health Policy and Technology, comprising articles that draw numerous lessons about effective pandemic policy from over 25 different countries. He also contributed as an author to several of these articles, such as one detailing  The first months of the COVID-19 pandemic in Spain and another about Categorising Policy & Technology Interventions for the Pandemic.

Knowledge transfer and translation

Professor Paolucci also understands the importance of translation to maximize the positive impact of his work and has designed and developed curricula at the postgraduate level for delivery on-campus, online, blended and transnationally in multiple universities worldwide. His most recent work is the development and implementation of the new Master Programs and Graduate Certificates in Health Economics, Management, and Policy (HEMP) here at the University of Newcastle. where Francesco was able to draw extensively from his previous experience with the international joint European Master of Health Economics and Management (Eu-HEM) in partnership with the University of Oslo, the University of Bologna, Management Centre, Innsbruck, and Erasmus University Rotterdam, and the Health Administration, Policy and Leadership (MHAPL) program at Murdoch University.

“Alongside my research and policy consultancy work, I am committed to addressing the global gap in health economics management and policy literacy through the development of courses and training programs in these areas.”

In addition to his work in program creation, Francesco is also a valued supervisor with the University of Newcastle, providing research and academic guidance for postgraduate students—many of whom are inspired to follow in his footsteps towards the advancement of the field of health economics and the improvement of global health outcomes.

“My students are contributing to society in many ways, in various parts of the world, and some have even publicly acknowledged that their enterprises were inspired by my courses.”

His work includes more than 55 peer-reviewed articles in world-class journals (and in multiple languages) such as the European Journal of Health Economics, as well as keynote conference speaking book chapters, book reviews and a single-authored book.

In all aspects of his work, Francesco is motivated by a deep commitment to global change and progress in health systems—especially for the world’s most vulnerable populations.

“In the last 200-300 years, we have seen health system successes that have helped to move more and more of the world out of poverty and away from disease. It is my personal and professional conviction that at the centre of sustainable societies there must be healthcare systems designed to improve wellbeing and welfare—these structures are pivotal for change.”

Professor Francesco Paolucci

Affordable healthcare at what cost?

Professor Francesco Paolucci is an internationally acclaimed scholar and advisor using research to enhance policy in economics and public health, resulting in more equitable and efficient healthcare for communities worldwide.

Read more

Career Summary

Biography

Dr Francesco Paolucci is Professor of Health Economics & Policy at the Faculty of Business & Law, University of Newcastle, Australia, and the School of Economics & Management, University of Bologna, Italy.

Before joining the University of Newcastle, he was Head of Health Policy at Sir Walter Murdoch of Public Policy and International Affairs, Murdoch University, Australia. Prof. Paolucci was formerly the Chief Advisor Health Reforms to Minister of Health in Chile in 2019 and is a current member of the Italian Technical Committee for Allocation of National Health Budget.

Prof. Paolucci has published over 60 academic peer-reviewed articles, book chapters and book reviews in a wide array of academic journals and presses, and in different languages. Among the others, he published a one single-authored book (“Health care financing and insurance options for design”. Publisher: Springer), leaded and coordinated the COVID-19 special issue for the peer-reviewed journal Health Policy and Technology and contributed with two chapters in a recent book describing the health insurance market and its financing (Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets. Edited by Thomas McGuire and Richard C. van Kleef. Publisher: Elsevier).

Prof. Paolucci is an associate editor for the world’s leading journals in health policy and economics, is an active journal reviewer and has a strong record of international research collaboration. Prof. Paolucci has extensive international experience working as chief advisor to think-tanks, governments and industry. He is currently chief investigator on grants funded by the Australian Research Council, the National Health Medical Research Council, the European Commission (Horizon2020). Prof. Paolucci has been awarded industry grants from public and private agencies. He participates extensively in academic activities, conducts innovative research training activities, and provides teaching programs nationally and overseas. He supervises a number of doctoral and master students nationally and abroad.

Highlights include: over 15 years of engagement in health economics, policy and management in various countries (e.g. Austria, Australia, Chile, China, Italy, the Netherlands, Norway, Qatar, South Africa, Spain, UK, USA) through research, fieldwork and consulting experiences. He was awarded the 40 Under 40 Awards by Business News (2016) and an Outstanding Business Engagement award by Murdoch University (2017).


Qualifications

  • Doctor of Philosophy, Erasmus University - Rotterdam

Keywords

  • Health Care Systems
  • Health Economics
  • Health Insurance and Financing
  • Health Reform
  • Healthcare management
  • Public Policy

Languages

  • English (Fluent)
  • Italian (Mother)
  • Spanish (Fluent)
  • French (Fluent)
  • Dutch (Working)

Fields of Research

Code Description Percentage
350206 Insurance studies 30
440706 Health policy 30
380108 Health economics 40

Professional Experience

UON Appointment

Title Organisation / Department
Casual Academic University of Newcastle
Newcastle Business School
Australia
Professor University of Newcastle
Newcastle Business School
Australia

Academic appointment

Dates Title Organisation / Department
1/5/2014 - 1/12/2018 Head of Health Administration, Policy & Leadership programs Murdoch University
Sir Walter Murdoch School of Public Policy & International Affairs
Australia
1/5/2014 - 1/11/2018 Associate Professor in Health Policy and Economics Murdoch University
Sir Walter Murdoch School of Public Policy & International Affairs
Australia
1/1/2014 -  Associate Professor University of Bologna
School of Economics and Management
Italy
1/1/2014 - 1/7/2014 Associate Professor of Health Policy The University of Western Australia
Australia
2/1/2012 - 1/5/2014 Reader in Health Policy and Economics Northumbria University
Department of Health Community and Education Studies
United Kingdom
3/1/2011 - 30/12/2011 Associate Fellow Stanford University
United States
2/7/2007 - 30/12/2011 Fellow in Health Economics Australian National University
Australia
30/4/2002 - 30/12/2007 Researcher and Co-Director of the MSc HEPL Erasmus University Rotterdam
Institute of Health Policy and Management
Netherlands

Membership

Dates Title Organisation / Department
1/8/2020 -  Member Australian Association of University Professors
Australia
1/1/2020 -  Member and creator of the Value in Health Economics and Policy group Value in Health Economics and Policy (VHEP)
Australia
3/1/2018 - 30/12/2018 Member of the local organising committee for the Precision Public Health International The University of Western Australia
Australia
2/1/2017 -  Associate Editor Health Policy and Technology Journal
Health Policy and Technology Journal
United States
1/4/2016 -  Associate Editor in Public Health Policy Frontiers
Public Health Policy
Switzerland
10/1/2014 -  Associate Fellow Australasian College of Health Service Management
Australia
2/1/2014 - 30/12/2015 Member of the International Collaborations Advisory Group Murdoch University
Sir Walter Murdoch School of Public Policy & International Affairs
Australia
2/1/2014 - 30/12/2015 Member of the Cockburn Initiative Feasibility Group Murdoch University
Australia
2/1/2014 - 30/12/2015 Member of the Health Initiative Task Force Fiona Stanley Hospital | Murdoch University | South Metro Health District WA
Australia
8/1/2007 -  Member Economic Society of Australia, NSW Chapter
Australia
2/1/2007 -  Member Australian Health Economic Society
Australia
1/1/2003 -  Permanent Member and Country Coordinator for Australia Risk Adjustment Network
Netherlands
7/1/2002 -  Member International Health Economics Association
Australia

Professional appointment

Dates Title Organisation / Department
1/7/2020 - 31/7/2020 Expert and Consultant for Charles River Associate Charles River Associates
Australia
1/5/2020 - 30/9/2020 Expert advisory Market Access Transformation
Australia
31/3/2020 - 31/7/2020 Consultant to Analyse NSW traffic data to assess the cost effectiveness of social distancing in COVID-19 times Hunter Research Foundation
1/3/2020 - 30/6/2020 Collaboration with MENZIS Center focusing on an analysis on the economic, finance and social impact of COVD-19 Menzies Foundation
1/3/2018 - 31/3/2019 Chief Advisor to the Ministry of Health on Health Insurance and Financing Reform Ministry of Health, Government of Chile
Chile
2/1/2018 - 30/12/2018 Associate Dean of Research Murdoch University
Sir Walter Murdoch School of Public Policy & International Affairs
Australia
18/1/2017 - 18/12/2017 Member of Italian National Health Technical Committee for the Allocation of Fund as Representative for Emilia-Romagna Region Servizio Sanitario Nazionale
Italy
7/1/2013 - 31/12/2013 Head of Health Insurance and Financing Supreme Council of Health (SCH)
Qatar

Awards

Award

Year Award
2017 Outstanding Business Engagement Research
Murdoch University
2016 40under40 Business News award in WA for entrepreneurial and business leadership
Business News
2013 Ones to watch
Mena Insurance Review
2009 ANU Vice-Chancellors grant for visiting international academic: Peter Zweifel
Australian National University
2008 Two ANU Vice-Chancellor's grants for visiting Eurropean and American universities and institutions, and for visiting international academic (John Armstrong, Chief Actuary VHI-Ireland)
Australian National University

Teaching

Code Course Role Duration
GSBS6384 Strategic Health Leadership and Management
Faculty of Business and Law University of Newcastle
The healthcare sector is in continuous evolution with complex simultaneous dynamics involving demographic and epidemiologic transitions, health technology and new models of healthcare, changes in healthcare funding algorithms and governance, and consumers and societal expectations about health outcomes and optimal mix of healthcare workforce. Strategic Health Leadership and Management introduces students to leadership and managerial approaches pertaining to health and social care organisations. Participants gain information on the implications of key challenges for strategic health leadership and management, and the skills to effectively anticipate and manage structural changes in health industries locally, nationally and internationally. The course distinguishes between Management, described as the production of acceptable results within known constraints and conditions; and Leadership, described as harnessing individual and organisational capacity, collaboration and character to facilitate strategic and productive changes within health organisations. Through the use of case studies presented by industry leaders and academic staff, theoretical and practical issues in healthcare leadership and management in Australian and global health industries will be discussed.
Course coordinator and Lecturer 29/1/2021 - 31/12/2023
GSBS6380 Health Economics and Finance
Newcastle Business School the University of Newcastle
Health economics is the application of economic principles to health and healthcare. Students apply core concepts of supply and demand theories to health and healthcare examples and learn about the importance of information (and information asymmetry) in health care markets; the critical role of insurance; hospital financing and delivery; and private/public mix in finance and provision of healthcare. In this course students are introduced to key conceptual frameworks of healthcare economics and decision making, and examine how Australian and international healthcare systems are designed and organised, including the critical components of long-term care and pharmaceutical markets.

Modality: Face to face and online
Course Coordinator and Lecturer 1/2/2020 - 30/12/2023
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Book (2 outputs)

Year Citation Altmetrics Link
2011 Paolucci F, Health care financing and insurance. Options for design. (2011)
DOI 10.1007/978-3-642-10794-8_1
Citations Scopus - 6
2011 Paolucci F, Stoelwinder J, Risk-equalisation in health insurance markets: Models and international experience, Australian Centre for Health Research, Melbourne, 36 (2011)

Chapter (6 outputs)

Year Citation Altmetrics Link
2018 Velasco C, Henriquez J, Paolucci F, Paolucci F, 'Health plan payment in Chile', Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets, Academic Press, London, UK 235-261 (2018) [B1]
DOI 10.1016/B978-0-12-811325-7.00008-7
Citations Scopus - 4
2018 Paolucci F, Sequeira AR, Fouda A, Matthews A, Matthews A, 'Health plan payment in Australia', Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets, Academic Press, United Kingdom 181-208 (2018) [B1]
DOI 10.1016/B978-0-12-811325-7.00006-3
Citations Scopus - 5
2016 García-Go ni M, McKiernan P, Paolucci F, 'Pathways towards health care systems with a chronic-care focus: Beyond the four walls', Boundaryless Hospital: Rethink and Redefine Health Care Management, Springer, Heidelberg, Germany 59-80 (2016) [B1]
DOI 10.1007/978-3-662-49012-9_4
Citations Scopus - 2
2012 Paolucci F, McRae IS, McRae IS, 'Healthcare delivery for our ageing population: what does Australia need to do?', A Greater Australia: Population, policies and governance, CEDA, Melbourne 162-174 (2012)
2011 Paolucci F, 'General Introduction', Developments in Health Economics and Public Policy, Springer Berlin Heidelberg 1-11 (2011)
DOI 10.1007/978-3-642-10794-8_1
2010 Paolucci F, Paolucci F, Henry E, Terry H, Jos A, 'The effectiveness of health informatics. In: Healthcare and the Effect of Technology. Medical Information Science Reference, Hershey, PA, USA, pp. 13-37. ISBN 978-1615207336', (2010)
Show 3 more chapters

Journal article (91 outputs)

Year Citation Altmetrics Link
2024 Berardi C, Arija Prieto P, Henríquez J, Paolucci F, 'Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public-private mix?', Health Econ Policy Law, 1-16 (2024) [C1]
DOI 10.1017/S1744133123000336
2024 van Kleef RC, Reuser M, Mcguire TG, Armstrong J, Beck K, Brammli-Greenberg S, et al., 'Scope and Incentives for Risk Selection in Health Insurance Markets With Regulated Competition: A Conceptual Framework and International Comparison', MEDICAL CARE RESEARCH AND REVIEW, [C1]
DOI 10.1177/10775587231222584
2024 Gebremariam AG, Abegaz D, Nigus HY, Argaw TL, Gerbaba M, Genie MG, Paolucci F, 'Vaccine uptake and effectiveness: Why some African countries performed better than the others?', Health Policy and Technology, 13 100820-100820 (2024) [C1]
DOI 10.1016/j.hlpt.2023.100820
Citations Scopus - 1
Co-authors Mesfin Genie
2024 Berardi C, Antonini M, Jordan Z, Wechtler H, Paolucci F, Hinwood M, 'Barriers and facilitators to the implementation of digital technologies in mental health systems: a qualitative systematic review to inform a policy framework.', BMC Health Serv Res, 24 243 (2024) [C1]
DOI 10.1186/s12913-023-10536-1
Co-authors Heidi Wechtler, Madeleine Hinwood
2024 Wong A, Zoller C, Fouda A, Paolucci F, 'Are we past the COVID-19 Pandemic? Insights from Singapore', Health Policy and Technology, 13 (2024) [C1]

Objective: This study aims to examine the interplay between high policy stringency, vaccination rates and epidemiological outcomes to develop insights on COVID-19 policy transitio... [more]

Objective: This study aims to examine the interplay between high policy stringency, vaccination rates and epidemiological outcomes to develop insights on COVID-19 policy transition in Singapore Methods: The CPTI (Categorising Policy & Technology Interventions) framework was used to classify reported interventions from January 2021 to October 2022. To analyse the impact of vaccine measures, an additional category was created. The highest monthly proportion of de-escalated measures was used as a basis to define the periods that mark the policy transition in Singapore i.e. Phase 2 and 3. Proportions of significantly escalated measures were calculated and analysed against full and booster vaccination rates, alongside epidemiological indicators ¿ monthly total number of infections and deaths, and monthly average active hospitalisation and ICU cases. Results: Implementation of highly stringent policies were observed to have reduced in intensity as vaccination rates picked up from Phase 2 to 3. Containment measures were the most frequently and consistently adopted beside vaccine policies. Epidemiological indicators appeared to be generally lower in Phase 3 than Phase 2. Specifically, despite reduced intensity of stringent polices, hospitalisation and ICU cases were observed to remain relatively low when vaccination rates were correspondingly higher in Phase 3 compared to Phase 2. Conclusion: The descriptive analysis of COVID-19 policy shift in Singapore based on selected indicators preliminarily suggested its successful transition from the pandemic to endemic phase in its response strategies. A policy transition plan should consider the significance of vaccination rates in an exit strategy that protects the population against worse health outcomes.

DOI 10.1016/j.hlpt.2023.100779
Citations Scopus - 2
2023 Henriquez J, Iommi M, McGuire T, Mentzakis E, Paolucci F, 'Designing feasible and effective health plan payments in countries with data availability constraints', Journal of Risk and Insurance, 90 33-57 (2023) [C1]

Risk equalization schemes, which transfer money to/from insurers that have above/below average risks, are a fundamental tool in regulated health insurance markets in many countrie... [more]

Risk equalization schemes, which transfer money to/from insurers that have above/below average risks, are a fundamental tool in regulated health insurance markets in many countries. Risk sharing (the transfer of some responsibility for costs from a plan to the regulator or the overall insurance market), are an additional method of insulating insurers who attract higher-than-average risks. This paper proposes, implements and quantifies incorporating risk sharing within a risk equalization scheme that can be applied in a data-poor context. Using Chile's private health insurance market as case study, we show that modest amount of risk sharing greatly improves fit even in simple demographic-based risk equalization. Expanding the model's formula to include morbidity-based adjustors and risk sharing redirects compensations at insurer level and reduces opportunity to engage in profitable risk selection at the group level. Our emphasis on feasibility may make alternatives proposed attractive to countries facing data-availability constraints.

DOI 10.1111/jori.12372
Citations Scopus - 4Web of Science - 1
2023 Klein PP, van Kleef R, Henriquez J, Paolucci F, 'The interplay between risk adjustment and risk rating in voluntary health insurance', JOURNAL OF RISK AND INSURANCE, 90 59-91 (2023) [C1]
DOI 10.1111/jori.12394
Citations Scopus - 4Web of Science - 4
2023 Moy N, Antonini M, Kyhlstedt M, Fiorentini G, Paolucci F, 'Standardising policy and technology responses in the immediate aftermath of a pandemic: a comparative and conceptual framework', HEALTH RESEARCH POLICY AND SYSTEMS, 21 (2023) [C1]
DOI 10.1186/s12961-022-00951-x
Citations Scopus - 6
2023 Schilling C, Tew M, Bunzli S, Shadbolt C, Lohmander LS, Balogh ZJ, et al., 'An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials.', Appl Health Econ Health Policy, 21 263-273 (2023) [C1]
DOI 10.1007/s40258-022-00775-4
Citations Scopus - 2
Co-authors Zsolt Balogh
2023 Moy N, Flynn D, Henriquez J, Connelly LB, Vale L, Paolucci F, 'Interventions for improving clinical outcomes and health-related quality-of-life for people living with skeletal dysplasias: an evidence gap map.', Qual Life Res, 32 2751-2762 (2023) [C1]
DOI 10.1007/s11136-023-03431-z
2023 Meusel V, Mentzakis E, Baji P, Fiorentini G, Paolucci F, 'Priority setting in the German healthcare system: results from a discrete choice experiment.', Int J Health Econ Manag, 23 411-431 (2023) [C1]
DOI 10.1007/s10754-023-09347-y
2023 Wynne O, Szewczyk Z, Hollis J, Farragher E, Doherty E, Tully B, et al., 'Study protocol for an economic evaluation and budget impact of implementation strategies to support routine provision of antenatal care for gestational weight gain: a stepped-wedge cluster trial', Implementation Science Communications, 4 (2023)

Background: Antenatal clinical practice guidelines recommend routine assessment of weight and provision of advice on recommended weight gain during pregnancy and referral to addit... [more]

Background: Antenatal clinical practice guidelines recommend routine assessment of weight and provision of advice on recommended weight gain during pregnancy and referral to additional services when appropriate. However, there are barriers to clinicians adopting such best-practice guidelines. Effective, cost-effective, and affordable implementation strategies are needed to ensure the intended benefits of guidelines are realised. This paper describes the protocol for evaluating the efficiency and affordability of implementation strategies compared to the usual practice in public antenatal services. Method: The prospective trial-based economic evaluation will identify, measure, and value key resource and outcome impacts arising from the implementation strategies compared with usual practice. The evaluation will comprise of (i) costing, (ii) cost-consequence analyses, where a scorecard approach will be used to show the costs and benefits given the multiple primary outcomes included in the trial, and (iii) cost-effectiveness analysis, where the primary outcome will be incremental cost per percent increase in participants reporting receipt of antenatal care for gestational weight gain consistent with the guideline recommendations. Affordability will be evaluated using (iv) budget impact assessment and will estimate the financial implications of adoption and diffusion of this implementation strategy from the perspective of relevant fund-holders. Discussion: Together with the findings from the effectiveness trial, the outcomes of this economic evaluation will inform future healthcare policy, investment allocation, and research regarding the implementation of antenatal care to support healthy gestational weight gain. Trial registration: Trial Registration: Australian and New Zealand Clinical Trials Registry, ACTRN12621000054819 (22/01/2021) http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380680&isReview=true .

DOI 10.1186/s43058-023-00420-8
Co-authors Jenna Hollis, John Wiggers, Olivia Wynne
2023 Antonini M, van Kleef RC, Henriquez J, Paolucci F, 'Can risk rating increase the ability of voluntary deductibles to reduce moral hazard?', Geneva Pap Risk Insur Issues Pract, 48 130-156 (2023) [C1]
DOI 10.1057/s41288-021-00253-3
Citations Web of Science - 1
2022 Berardi C, Lee ES, Wechtler H, Paolucci F, 'A vicious cycle of health (in)equity: Migrant inclusion in light of COVID-19', Health Policy and Technology, 11 (2022) [C1]

Objectives: Whilst mass vaccination is suggested as an important means to contain COVID-19 pandemic, vaccination policies across many countries have systematically excluded some g... [more]

Objectives: Whilst mass vaccination is suggested as an important means to contain COVID-19 pandemic, vaccination policies across many countries have systematically excluded some groups of population, especially migrants. This study aims to document the impact of diversified vaccination strategies as a preventative and control measure for the health and safety of the wider population within a country. Methods: We selected five countries that have experienced the changes in migrant inflows to the most extreme among OECD countries in 2020: The United States, Australia, Canada, Japan, and South Korea. We conducted an extensive qualitative documentary analysis focused on policies and interventions implemented in these countries since January 2020 till the end of September 2021. We also analyzed publicly available epidemiological data (released by the governments and other international organizations). Results: We find that achieving migrants¿ health and vaccination equity is not without challenges, and a failure to address those multiplicity of concerns may result in a vicious cycle for the vulnerable population at the fringes of our economy. Migrants continue to face extenuating circumstances with higher risks to their health and safety, when they are excluded or disadvantaged in vaccination policies. The more inclusive and proactive the governments are in consideration of diversity of migrant populations, the better they can manage the pandemic, which leads to overall societal benefit of ensuring public health. Conclusions: Equity-based policies can mitigate disparities in access to vaccination and healthcare, thereby reducing the spread of COVID-19 in the community.

DOI 10.1016/j.hlpt.2022.100606
Citations Scopus - 12Web of Science - 6
Co-authors Heidi Wechtler, Jeannie Lee
2022 Smits M, Henriquez J, Melia A, Paolucci F, 'Stability of Private Health Insurance in Australia: Analysis and Proposal of a Legislative Framework to Boost Participation', Australian Business Law Review, 50 291-300 (2022) [C1]
DOI 10.3316/agispt.20221215079856
Co-authors Adrian Melia
2022 Antonini M, Hinwood M, Paolucci F, Balogh ZJ, 'The Epidemiology of Major Trauma During the First Wave of COVID-19 Movement Restriction Policies: A Systematic Review and Meta-analysis of Observational Studies', WORLD JOURNAL OF SURGERY, 46 2045-2060 (2022) [C1]
DOI 10.1007/s00268-022-06625-7
Citations Scopus - 9Web of Science - 6
Co-authors Madeleine Hinwood, Zsolt Balogh
2022 Gillespie JA, Buchanan J, Schneider CH, Paolucci F, 'Covid 19 Vaccines and the Australian health care state', HEALTH POLICY AND TECHNOLOGY, 11 (2022) [C1]
DOI 10.1016/j.hlpt.2022.100607
Citations Scopus - 7Web of Science - 5
2022 Hinwood M, Wall L, Lang D, Balogh ZJ, Smith A, Dowsey M, et al., 'Patient and clinician characteristics and preferences for increasing participation in placebo surgery trials: a scoping review of attributes to inform a discrete choice experiment', TRIALS, 23 (2022) [C1]
DOI 10.1186/s13063-022-06277-x
Citations Scopus - 1Web of Science - 1
Co-authors Madeleine Hinwood, Laura Wall, Danielle Lang, Zsolt Balogh
2022 Douven R, Kauer L, Demme S, Paolucci F, van de Ven W, Wasem J, Zhao X, 'Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries', EUROPEAN JOURNAL OF HEALTH ECONOMICS, 23 1437-1453 (2022) [C1]
DOI 10.1007/s10198-022-01436-y
Citations Scopus - 2Web of Science - 1
2022 Antonini M, Eid MA, Falkenbach M, Rosenbluth ST, Prieto PA, Brammli-Greenberg S, et al., 'An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes.', Health Policy Technol, 11 100594 (2022) [C1]
DOI 10.1016/j.hlpt.2021.100594
Citations Scopus - 31Web of Science - 8
2022 Fouda A, Melia A, Tritter J, Paolucci F, 'Special Issue: The COVID-19 pandemic: Vaccination strategies and global health policies', HEALTH POLICY AND TECHNOLOGY, 11 (2022)
DOI 10.1016/j.hlpt.2022.100634
Citations Scopus - 1
Co-authors Adrian Melia
2022 Iommi M, Bergquist S, Fiorentini G, Paolucci F, 'Comparing risk adjustment estimation methods under data availability constraints', HEALTH ECONOMICS, 31 1368-1380 (2022) [C1]
DOI 10.1002/hec.4512
Citations Scopus - 2
2022 Desson Z, Kauer L, Otten T, Peters JW, Paolucci F, 'Finding the way forward: COVID-19 vaccination progress in Germany, Austria and Switzerland', Health Policy and Technology, 11 (2022) [C1]

Objectives: : This paper presents an overview of the procurement and deployment of COVID-19 vaccinations in Germany, Austria and Switzerland (DACH) from the success of the first v... [more]

Objectives: : This paper presents an overview of the procurement and deployment of COVID-19 vaccinations in Germany, Austria and Switzerland (DACH) from the success of the first vaccine trials until the end of August 2021. Data regarding vaccination procurement and deployment is presented, followed by an analysis of the challenges these countries face in improving their vaccination rates. Methods: : A review and analysis of available data from the DACH countries was conducted. Data was collected from official government sources whenever possible and supplemented by information from international databases and local reports. The data was analyzed to identify common patterns as well as divergences across the DACH region, especially as they relate to vaccine hesitancy and health policy. Results: : Following initial global supply problems, the DACH countries were largely successful at administering vaccinations to their populations. However, by the end of August 2021 their vaccination progress had plateaued. This was primarily due to vaccine hesitancy in the region, which is correlated with a multitude of complex factors. These factors need to be better understood before this issue can be effectively addressed. Unlike other countries, the DACH countries have not (yet) used financial incentives or mandates to increase vaccination rates. Conclusions: : The DACH countries displayed effective governance in their deployment of COVID-19 vaccines, but vaccine hesitancy is slowing progress. Due to various social and political factors, Germany, Austria and Switzerland have not been able to employ effective policy levers to overcome this barrier and a more nuanced strategy will have to be developed. Public Interest Summary: : Germany, Austria and Switzerland (DACH) were largely successful at procuring COVID-19 vaccine doses and administering them to their populations. After the first doses were acquired, their vaccination rates continued to steadily rise, but progress began to slow down substantially by August 2021 due in part to vaccine hesitancy. Unlike in other countries, the DACH governments have not been able to implement vaccine mandates to try and overcome this issue due to their specific political and social circumstances. A deeper understanding of the factors driving vaccine hesitancy in the region will be required before effective solutions can be found.

DOI 10.1016/j.hlpt.2021.100584
Citations Scopus - 19Web of Science - 12
2022 Dzator J, Acheampong AO, Dzator M, Paolucci F, Yawe BL, Asmah EE, et al., 'Policy Stringency, Handwashing and COVID-19 cases: Evidence from Global dataset', Health Policy and Technology, 11 (2022) [C1]

Objective:: Since the COVID-19 pandemic, many governments globally have introduced policy measures to contain the spread of the virus. Popular COVID-19 containment measures includ... [more]

Objective:: Since the COVID-19 pandemic, many governments globally have introduced policy measures to contain the spread of the virus. Popular COVID-19 containment measures include lockdowns of various forms (aggregated into government response stringency index [GRSI]) and handwashing (HWF). The effectiveness of these policy measures remains unclear in the academic literature. This study, therefore, examines the effect of government policy stringency and handwashing on total daily reported COVID-19 cases. Method:: We use a comprehensive dataset of 176 countries to investigate the effect of government policy stringency and handwashing on daily reported COVID-19 cases. In this study, we apply the Lewbel (2012) two-stage least squares technique to control endogeneity. Results:: Our results indicated that GRSI significantly contributes to the increase in the total and new confirmed cases of COVI-19. Sensitivity analyses revealed that the 1st, 4th, and 5th quintiles of GRIS significantly reduce total confirmed cases of COVID-19. Also, the result indicated that while the 1st quintile of GRIS contributes significantly to reducing the new confirmed cases of COVID-19, the 3rd, 4th, and 5th quintiles of GRSI contribute significantly to increasing the new confirmed cases of COVID-19. The results indicated that HWF reduces total and new confirmed cases of COVID-19; however, such effect is not robust to income and regional effects. Nonlinear analysis revealed that while GRSI has an inverted U-shaped relationship with total and new confirmed cases of COVID-19, HWF has a U-shaped relationship. Conclusion:: We suggest that policymakers should focus on raising awareness and full engagement of all members of society in implementing public health policies rather than using stringent lockdown measures.

DOI 10.1016/j.hlpt.2021.100574
Citations Scopus - 12Web of Science - 3
Co-authors Janet Dzator
2021 Sequeira AR, Mentzakis E, Archangelidi O, Paolucci F, 'The economic and health impact of rare diseases: A meta-analysis', Health Policy and Technology, 10 32-44 (2021) [C1]

Objective: Lack of medical and scientific knowledge on rare diseases (RD) often translates into limited research on them and a subsequent lack of understanding of their economic i... [more]

Objective: Lack of medical and scientific knowledge on rare diseases (RD) often translates into limited research on them and a subsequent lack of understanding of their economic impact. This meta-analysis aims to fill this gap by evaluating the economic impact of RDs and exploring potential factors associated with the societal burden of RD. Methods: Studies published between January 2010 and February 2017 were identified by searches in the PubMed platform. Thirty eligible studies were identified for inclusion, and nineteen studies were included in the meta-analysis and outcomes were explored. The cost categories include direct healthcare costs, direct non-healthcare formal costs, and direct non-healthcare informal costs. The patients¿ health-related quality of life (QoL) dimensions examined include EQ-5D scores, VAS scores and Barthel index, and the carers¿ utility outcomes include EQ-5d scores, VAS scores and Zarit scale. Random effects meta-regression models were used for modelling the impact of study and societal characteristics on cost. Results: Across all RDs, mean direct healthcare (DH) costs ($16,513) account for the majority of direct costs (mainly driven by drug costs), followed by mean direct healthcare informal (¿15,557) and mean direct healthcare formal (¿4,579) costs. Body system affected by the RD, Gross Domestic Product (GDP) per capita and public health expenditure in country of study were the most significant determinants in predicting cost. In regards to QoL outcomes, patients with musculoskeletal diseases seem to have the lowest quality of life across EQ-5D scores, VAS scores and Barthel index. The burden on caregivers seemed to be associated with Autoimmune, followed by Musculoskeletal and Respiratory conditions. Conclusions: This meta-analysis highlights the significant burden of RDs on the health care system and explicitly provides evidence for the magnitude of this impact. Such estimates are necessary to further the debate on priority setting around RDs and their comparison with other chronic diseases. Nevertheless, the large degree of cost variability across RDs might suggest that the use of umbrella terms to raise awareness around RDs¿ societal impact might not be warranted.

DOI 10.1016/j.hlpt.2021.02.002
Citations Scopus - 10Web of Science - 7
2021 Berardi C, Hinwood M, Smith A, Melia A, Paolucci F, 'Barriers and facilitators to the integration of digital technologies in mental health systems: A protocol for a qualitative systematic review', PLOS ONE, 16 (2021)
DOI 10.1371/journal.pone.0259995
Citations Scopus - 4Web of Science - 2
Co-authors Madeleine Hinwood, Adrian Melia
2021 Melia A, Lee D, Mahmoudi N, Li Y, Paolucci F, 'Cost-Effectiveness Analysis of COVID-19 Case Quarantine Strategies in Two Australian States: New South Wales and Western Australia', Journal of Risk and Financial Management, 14 305-305 (2021) [C1]
DOI 10.3390/jrfm14070305
Citations Scopus - 3Web of Science - 1
Co-authors Adrian Melia
2021 Kingsland M, Hollis J, Farragher E, Wolfenden L, Campbell K, Pennell C, et al., 'An implementation intervention to increase the routine provision of antenatal care addressing gestational weight gain: study protocol for a stepped-wedge cluster trial', Implementation Science Communications, 2 (2021)

Background: Weight gain during pregnancy that is outside of recommended levels is associated with a range of adverse outcomes for the mother and child, including gestational diabe... [more]

Background: Weight gain during pregnancy that is outside of recommended levels is associated with a range of adverse outcomes for the mother and child, including gestational diabetes, pre-eclampsia, preterm birth, and obesity. Internationally, 60¿80% of pregnant women report gaining weight outside of recommended levels. While guideline recommendations and RCT evidence support the provision of antenatal care that supports healthy gestational weight gain, less than 10% of health professionals routinely weigh pregnant women; discuss weight gain, diet, and physical activity; and provide a referral for additional support. This study aims to determine the effectiveness of an implementation intervention in increasing the provision of recommended gestational weight gain care by maternity services. Methods: A stepped-wedge controlled trial, with a staggered implementation intervention, will be conducted across maternity services in three health sectors in New South Wales, Australia. The implementation¿intervention will consist of evidence-based, locally-tailored strategies including guidelines and procedures, reminders and prompts, leadership support, champions, training, and monitoring and feedback. Primary outcome measures will be the proportion of women who report receiving (i) assessment of gestational weight gain; (ii) advice on gestational weight gain, dietary intake, and physical activity; and (iii) offer of referral to a telephone coaching service or local dietetics service. Measurement of outcomes will occur via telephone interviews with a random sample of women who attend antenatal appointments each week. Economic analyses will be undertaken to assess the cost, cost-consequence, cost-effectiveness, and budget impact of the implementation intervention. Receipt of all care elements, acceptance of referral, weight gain during pregnancy, diet quality, and physical activity will be measured as secondary outcomes. Process measures including acceptability, adoption, fidelity, and reach will be reported. Discussion: This will be the first controlled trial to evaluate the effectiveness of a implementation intervention in improving antenatal care that addresses gestational weight gain. The findings will inform decision-making by maternity services and policy agencies and, if the intervention is demonstrated to be effective, could be applied at scale to benefit the health of women and children across Australia and internationally. Trial registration: Australian and New Zealand Clinical Trials Registry, ACTRN12621000054819 . Registered on 22 January 2021.

DOI 10.1186/s43058-021-00220-y
Citations Scopus - 1
Co-authors Luke Wolfenden, Christopher Oldmeadow, John Wiggers, Craig Pennell, Maralyn Foureur, Jenna Hollis
2021 Bunzli S, Choong E, Shadbolt C, Wall L, Nelson E, Schilling C, et al., 'Placebo Surgery Controlled Trials: Do They Achieve What They Set Out To Do? A Systematic Review.', Ann Surg, 273 1102-1107 (2021) [C1]
DOI 10.1097/SLA.0000000000004719
Citations Scopus - 4Web of Science - 5
Co-authors Laura Wall, Zsolt Balogh
2021 Bunzli S, Nelson E, Wall L, Schilling C, Lohmander LS, Balogh ZJ, et al., 'Factors Underlying Patient and Surgeon Willingness to Participate in a Placebo Surgery Controlled trial', Annals of Surgery Open, 2 e104-e104 [C1]
DOI 10.1097/as9.0000000000000104
Co-authors Zsolt Balogh, Laura Wall
2020 Higginson S, Milovanovic K, Gillespie J, Matthews A, Williams C, Wall L, et al., 'COVID-19: The need for an Australian economic pandemic response plan', Health Policy and Technology, 9 488-502 (2020) [C1]

Objectives: Pandemics pressure national governments to respond swiftly. Mitigation efforts created an imbalance between population health, capacity of the healthcare system and ec... [more]

Objectives: Pandemics pressure national governments to respond swiftly. Mitigation efforts created an imbalance between population health, capacity of the healthcare system and economic prosperity. Each pandemic arising from a new virus is unknown territory for policy makers, and there is considerable uncertainty of the appropriateness of responses and outcomes. Methods: A qualitative approach was used to review mixed sources of data including Australian reports, official government publications, and COVID-19 data to discern robust future responses. Publicly available epidemiological and economic data were utilised to provide insight into the impact of the pandemic on Australia's healthcare system and economy. Results: Policies implemented by the Australian Government to mitigate the spread of COVID-19 impacted the healthcare sector and economy. This paper incorporates lessons learned to inform optimal economic preparedness. The rationale for an economic response plan concomitant with the health pandemic plan is explored to guide Australian Government policy makers in ensuring holistic and robust solutions for future pandemics. Conclusions: In future, an Australian Economic Pandemic Response Plan will aid in health and economic system preparedness, whilst a strong Australian economy and strategic planning will ensure resilience to future pandemics.

DOI 10.1016/j.hlpt.2020.08.017
Citations Scopus - 21Web of Science - 14
Co-authors Laura Wall, Christopher M Williams, Madeleine Hinwood, Adrian Melia
2020 Henríquez J, Gonzalo-Almorox E, García-Goñi M, Paolucci F, Paolucci F, 'The first months of the COVID-19 pandemic in Spain.', Health policy and technology, 9 560-574 (2020) [C1]
DOI 10.1016/j.hlpt.2020.08.013
Citations Scopus - 42Web of Science - 34
2020 Benítez MA, Velasco C, Sequeira AR, Henríquez J, Menezes FM, Paolucci F, Paolucci F, 'Responses to COVID-19 in five Latin American countries.', Health policy and technology, 9 525-559 (2020) [C1]
DOI 10.1016/j.hlpt.2020.08.014
Citations Scopus - 129Web of Science - 98
2020 Fouda A, Mahmoudi N, Moy N, Paolucci F, 'The COVID-19 pandemic in Greece, Iceland, New Zealand, and Singapore: Health policies and lessons learned', Health Policy and Technology, 9 510-524 (2020) [C1]

Objective(s): This paper aims at providing an overview of the COVID-19 situation, health policies, and economic impact in Greece, Iceland, New Zealand, and Singapore. The four cou... [more]

Objective(s): This paper aims at providing an overview of the COVID-19 situation, health policies, and economic impact in Greece, Iceland, New Zealand, and Singapore. The four countries were chosen due to their ability to contain the spread and mitigate the effects of COVID-19 on their societies. Method(s): We use document analysis based on the available national reports, media announcements, official coronavirus websites and governmental decrees in each of the four countries starting from the 1st of January o the 9th of August announcements. We apply a policy gradient to compare and examine the policies implemented in the four countries. Finding(s): The four countries have different demographic, epidemiological, socioeconomic profiles but managed to control the pandemic at an early stage in terms of total number of positive cases. The four countries managed to absorb the health system shock and decrease the case fatality ratio of COVID-19. Early interventions were crucial to avoid expected life lost in case of no early lockdown. The pandemic triggered several economic stimulus and relief measures in the four countries; the impact or the economic rebound is yet to be fully observed. Conclusion(s): We conclude that early, proactive and strict interventions along with leveraging previous experience on communicable diseases and the evolution of testing strategies are key lessons that can be synthesized from the interventions of the four countries and that could be useful for a potential second wave or similar pandemics.

DOI 10.1016/j.hlpt.2020.08.015
Citations Scopus - 42Web of Science - 36
2020 Berardi C, Antonini M, Genie MG, Cotugno G, Lanteri A, Melia A, Paolucci F, 'The COVID-19 pandemic in Italy: Policy and technology impact on health and non-health outcomes', Health Policy and Technology, 9 454-487 (2020) [C1]

Background: Italy was the first Western country to experience a major coronavirus outbreak and consequently faced large-scale health and socio-economic challenges. The Italian gov... [more]

Background: Italy was the first Western country to experience a major coronavirus outbreak and consequently faced large-scale health and socio-economic challenges. The Italian government enforced a wide set of homogeneous interventions nationally, despite the differing incidences of the virus throughout the country. Objective: The paper aims to analyse the policies implemented by the government and their impact on health and non-health outcomes considering both scaling-up and scaling-down interventions. Methods: To categorise the policy interventions, we rely on the comparative and conceptual framework developed by Moy et al. (2020). We investigate the impact of policies on the daily reported number of deaths, case fatality rate, confirmation rate, intensive care unit saturation, and financial and job market indicators across the three major geographical areas of Italy (North, Centre, and South). Qualitative and quantitative data are gathered from mixed sources: Italian national and regional institutions, National Health Research and international organisations. Our analysis contributes to the literature on the COVID-19 pandemic by comparing policy interventions and their outcomes. Results: Our findings suggest that the strictness and timing of containment and prevention measures played a prominent role in tackling the pandemic, both from a health and economic perspective. Technological interventions played a marginal role due to the inadequacy of protocols and the delay of their implementation. Conclusions: Future government interventions should be informed by evidence-based decision making to balance, the benefits arising from the timing and stringency of the interventions against the adverse social and economic cost, both in the short and long term.

DOI 10.1016/j.hlpt.2020.08.019
Citations Scopus - 67Web of Science - 50
Co-authors Adrian Melia, Mesfin Genie
2020 Lee D, Moy N, Tritter J, Paolucci F, 'The COVID-19 pandemic: Global health policy and technology responses in the making', HEALTH POLICY AND TECHNOLOGY, 9 397-398 (2020)
DOI 10.1016/j.hlpt.2020.10.001
Citations Scopus - 10Web of Science - 8
2020 Matthews A, Paolucci F, Henriquez J, 'Private Health, COVID-19 and Agility in Healthcare', Actuaries Digital, (2020)
2020 Wall L, Hinwood M, Lang D, Smith A, Bunzli S, Clarke P, et al., 'Attitudes of patients and surgeons towards sham surgery trials: a protocol for a scoping review of attributes to inform a discrete choice experiment', BMJ OPEN, 10 (2020)
DOI 10.1136/bmjopen-2019-035870
Citations Scopus - 2Web of Science - 2
Co-authors Danielle Lang, Laura Wall, Madeleine Hinwood
2020 Mahmoudi N, Melia A, Lee D, Craig D, Paolucci F, 'Cost-effectiveness Analysis of COVID-19 Case Isolation (2020)
DOI 10.2139/ssrn.3603711
2019 Mortimer-Jones S, Morrison P, Munib A, Paolucci F, Neale S, Hellewell A, et al., 'Staff and client perspectives of the Open Borders programme for people with borderline personality disorder.', International Journal of Mental Health Nursing, 28 971-979 (2019) [C1]
DOI 10.1111/inm.12602
Citations Scopus - 12Web of Science - 9
2019 Henriquez J, Matthews A, Paolucci F, Stolz A, 'Private health and health care financing Learning from the world', The Institute of Actuaries of Australia - The Dialogue, (2019)
2019 Mentzakis E, García-Goñi M, Sequeira AR, Paolucci F, 'Equity and efficiency priorities within the Spanish health system: A discrete choice experiment eliciting stakeholders preferences', Health Policy and Technology, 8 30-41 (2019) [C1]

Background: The trade-off between efficiency and equity has been largely studied in the health economics literature and for countries with different types of health systems. Even ... [more]

Background: The trade-off between efficiency and equity has been largely studied in the health economics literature and for countries with different types of health systems. Even if efficiency and equity are desired, it is not always feasible to attain both simultaneously. In Spain, the National Health System has historically been recognized for its universal access and free of charge provision, with good health outcomes. However, the recent increase in health expenditures together with the economic cycle has turned the orientation of health policy implementation towards efficiency, threatening universality and equity in the access to healthcare. Methods: A Discrete Choice Experiment was carried out to weigh priorities of policy-makers from different regions in Spain. A total of 69 valid questionnaires were collected and the preferences towards equity and/or efficiency criteria were evaluated. Composite League Tables (CLTs) were used to rank hypothetical health interventions based on their attributes. Results: The Spanish health policy-makers, managers and other stakeholder displayed a stronger preference for severity of disease, high individual benefits, a large number of beneficiaries and proven cost-effectiveness criteria in decision making. The priority interventions targeted severe mental disorders, i.e. major depressive disorders and suicides (or suicidal attempts), especially for young and middle age categories across the three regions under study. Conclusion: In times of economic crisis, health policy-makers, managers and other stakeholder value, in moderation, efficiency over equity. The impact of austerity measures on populations¿ socio-economic wellbeing seems correlated with the preference for mental health interventions.

DOI 10.1016/j.hlpt.2019.01.003
Citations Scopus - 6Web of Science - 3
2018 Hasanova R, Mentzakis E, Paolucci F, Shmueli A, 'Beyond DRG: The effect of socio-economic indicators on inpatient resource allocation in Australia', Health Policy and Technology, 7 302-309 (2018) [C1]

Financing in Australia's public hospital works through the Australian Refined Diagnosis Related Groups (AR-DRGs) with separations to specific DRG groups based on medical diag... [more]

Financing in Australia's public hospital works through the Australian Refined Diagnosis Related Groups (AR-DRGs) with separations to specific DRG groups based on medical diagnosis or surgical procedure, patient's age, mode of separation, clinical complexity and complications. This paper aims at assessing how the AR-DRGs reflect the efficiency and equity of the hospitals resource allocation. Using administrative data of all acute public hospital admissions and length of stay (LOS) as a proxy for hospital costs, this paper showed that patients¿ socio-economic (SES) characteristics are a strong determinant of health care utilization. Our results revealed that the lower the SES, the longer the LOS and hence more utilization of the inpatient resources. Therefore, omitting SES from the risk adjusters list and solely focusing on DRG- based compensation penalizes hospitals catering to lower SES populations. Our findings further support the idea of smaller/remote hospitals based on block funding.

DOI 10.1016/j.hlpt.2018.07.001
Citations Scopus - 3Web of Science - 2
2018 García-Goñi M, Fouda A, Calder RV, Paolucci F, 'A new funding model for a chronic-care focused healthcare system in Australia', Health Policy and Technology, 7 293-301 (2018) [C1]

Objectives: Significant increases in health expenditures have been a global trend and constitute a major concern in Australia and other countries for healthcare providers, payers,... [more]

Objectives: Significant increases in health expenditures have been a global trend and constitute a major concern in Australia and other countries for healthcare providers, payers, policymakers, consumers and population. This trend is largely attributable to emerging healthcare technologies, aging populations, and the impact of non-communicable diseases and chronic conditions on the burden of disease. In this paper, we look at how the Australian health system is responding to this challenge. Methods: We analyze the main drivers of health expenditure with particular focus on chronic care and integrated care and provide an assessment of the most important problems. Results: The key challenge for Australia is how to reorient and rearrange current health funding and service organization through better design with a specific focus on long-term care and chronic care, prevention and early intervention in the search for efficiency in social and economic impacts and costs. We propose that this is most efficiently achieved through a publicly-funded health insurance model focused on chronic health conditions that we name Mandatory Integrated (Public and Private) Health Insurance (MIPPHI). MIPPHI meets the essential foundational components in terms of competitiveness, efficiency, and affordability. Conclusion: We articulate our proposal for a systematic health funding reform in 22 policy actions that, we argue, would improve the sustainability of the Australian health system while preserving its universal character for a more comprehensive basket of chronic and social services.

DOI 10.1016/j.hlpt.2018.07.007
Citations Scopus - 8Web of Science - 6
2017 Fouda A, Fiorentini G, Paolucci F, 'Competitive Health Markets and Risk Equalisation in Australia: Lessons Learnt from Other Countries', Applied Health Economics and Health Policy, 15 745-754 (2017) [C1]

The aims of this paper are to evaluate the risk equalisation (RE) arrangement in Australia¿s private health insurance against practices in other countries with similar arrangement... [more]

The aims of this paper are to evaluate the risk equalisation (RE) arrangement in Australia¿s private health insurance against practices in other countries with similar arrangements and to propose ways of improving the system to advance economic efficiency and solidarity. Possible regulatory responses to insurance market failures are reviewed based on standard economic arguments. We describe various regulatory strategies used elsewhere to identify essential system features against which the Australian system is compared. Our results reveal that RE is preferred over alternative regulatory strategies such as premium rate restrictions, premium compensation and claims equalisation. Compared with some countries¿ practices, the calculated risk factors in Australia should be enhanced with further demographic, social and economic factors and indicators of long-term health issues. Other coveted features include prospective calculation and annual clearing of equalisation payments. Australia currently operates with a crude mechanism for RE in which the scheme incentivises insurers to select on risk rather than focusing on efficiency and equity-promoting actions. System changes should be introduced in a stepwise manner; thus, we propose an incremental reform.

DOI 10.1007/s40258-017-0330-1
Citations Scopus - 2
2017 Paolucci F, Redekop K, Fouda A, Fiorentini G, 'Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage', Applied Health Economics and Health Policy, 15 697-706 (2017) [C1]

Health technology assessment (HTA) is widely viewed as an essential component in good universal health coverage (UHC) decision-making in any country. Various HTA tools and metrics... [more]

Health technology assessment (HTA) is widely viewed as an essential component in good universal health coverage (UHC) decision-making in any country. Various HTA tools and metrics have been developed and refined over the years, including systematic literature reviews (Cochrane), economic modelling, and cost-effectiveness ratios and acceptability curves. However, while the cost-effectiveness ratio is faithfully reported in most full economic evaluations, it is viewed by many as an insufficient basis for reimbursement decisions. Emotional debates about the reimbursement of cancer drugs, orphan drugs, and end-of-life treatments have revealed fundamental disagreements about what should and should not be considered in reimbursement decisions. Part of this disagreement seems related to the equity-efficiency tradeoff, which reflects fundamental differences in priorities. All in all, it is clear that countries aiming to improve UHC policies will have to go beyond the capacity building needed to utilize the available HTA toolbox. Multi-criteria decision analysis (MCDA) offers a more comprehensive tool for reimbursement decisions where different weights of different factors/attributes can give policymakers important insights to consider. Sooner or later, every country will have to develop their own way to carefully combine the results of those tools with their own priorities. In the end, all policymaking is based on a mix of facts and values.

DOI 10.1007/s40258-017-0349-3
Citations Scopus - 9Web of Science - 7
2017 Shmueli A, Golan O, Paolucci F, Mentzakis E, 'Efficiency and equity considerations in the preferences of health policy-makers in Israel', Israel Journal of Health Policy Research, 6 (2017) [C1]

Background: There is a traditional tension in public policy between the maximization of welfare from given resources (efficiency) and considerations related to the distribution of... [more]

Background: There is a traditional tension in public policy between the maximization of welfare from given resources (efficiency) and considerations related to the distribution of welfare among the population and to social justice (equity). The aim of this paper is to measure the relative weights of the efficiency- and equity-enhancing criteria in the preferences of health policy-makers in Israel, and to compare the Israeli results with those of other countries. Methods: We used the criteria of efficiency and equity which were adopted in a previous international study, adapted to Israel. The equity criteria, as defined in the international study, are: severity of the disease, age (young vs. elderly), and the extent to which the poor are subsidized. Efficiency is represented by the criteria: the potential number of beneficiaries, the extent of the health benefits to the patient, and the results of economic assessments (cost per QALY gained). We contacted 147 policy-makers, 65 of whom completed the survey (a response rate of 44%). Using Discrete Choice Experiment (DCE) methodology by 1000Minds software, we estimated the relative weights of these seven criteria, and predicted the desirability of technologies characterized by profiles of the criteria. Results: The overall weight attached to the four efficiency criteria was 46% and that of the three equity criteria was 54%. The most important criteria were "financing of the technology is required so that the poor will be able to receive it" and the level of individual benefit. "The technology is intended to be used by the elderly" criterion appeared as the least important, taking the seventh place. Policy-makers who had experience as members of the Basket Committee appear to prefer efficiency criteria more than those who had never participated in the Basket Committee deliberations. While the efficiency consideration gained preference in most countries studied, Israel is unique in its balance between the weights attached to equity and efficiency considerations by health policy-makers. Discussion: The study explored the trade-off between efficiency and equity considerations in the preferences of health policy-makers in Israel. The way these declarative preferences have been expressed in actual policy decisions remains to be explored.

DOI 10.1186/s13584-017-0142-7
Citations Scopus - 13Web of Science - 8
2017 Fouda A, Paolucci F, 'Path Dependence and Universal Health Coverage: The Case of Egypt.', Front Public Health, 5 325 (2017) [C1]
DOI 10.3389/fpubh.2017.00325
Citations Scopus - 7Web of Science - 6
2016 Strazdins L, Welsh J, Korda R, Broom D, Paolucci F, 'Not all hours are equal: Could time be a social determinant of health?', Sociology of Health and Illness, 38 21-42 (2016) [C1]

Time can be thought of as a resource that people need for good health. Healthy behaviour, accessing health services, working, resting and caring all require time. Like other resou... [more]

Time can be thought of as a resource that people need for good health. Healthy behaviour, accessing health services, working, resting and caring all require time. Like other resources, time is socially shaped, but its relevance to health and health inequality is yet to be established. Drawing from sociology and political economy, we set out the theoretical basis for two measures of time relevant to contemporary, market-based societies. We measure amount of time spent on care and work (paid and unpaid) and the intensity of time, which refers to rushing, effort and speed. Using data from wave 9 (N = 9177) of the Household, Income and Labour Dynamics of Australia Survey we found that time poverty (> 80 h per week on care and work) and often or always rushing are barriers to physical activity and rushing is associated with poorer self-rated and mental health. Exploring their social patterning, we find that time-poor people have higher incomes and more time control. In contrast, rushing is linked to being a woman, lone parenthood, disability, lack of control and work-family conflicts. We supply a methodology to support quantitative investigations of time, and our findings underline time's dimensionality, social distribution and potential to influence health.

DOI 10.1111/1467-9566.12300
Citations Scopus - 77Web of Science - 51
2016 Mortimer-Jones S, Morrison P, Munib A, Paolucci F, Neale S, Bostwick A, Hungerford C, 'Recovery and Borderline Personality Disorder: A Description of the Innovative Open Borders Program', Issues in Mental Health Nursing, 37 624-630 (2016) [C1]

Although Recovery-oriented approaches to delivering mental health services are now promoted in health services across the globe, there is an ongoing need to adapt these approaches... [more]

Although Recovery-oriented approaches to delivering mental health services are now promoted in health services across the globe, there is an ongoing need to adapt these approaches to meet the unique needs of consumers with a diagnosis of borderline personality disorder. The lived experience of borderline personality disorder includes emotional dysregulation, intense and unstable relationships, self-harming behaviours, fear of abandonment, and a limited capacity to cope with stress. These experiences present a range of challenges for those who deliver Recovery-oriented services and advocate the principles of empowerment and self-determination. This paper describes a novel crisis intervention program, ¿Open Borders,¿ which has been established to meet the unique needs of people with a borderline personality disorder diagnosis. Open Borders is a Recovery-oriented model that is run at a public, state-wide residential facility for mental health consumers in Western Australia, and offers alternative pathways to achieving mental health Recovery, including self-referral and short-term admission to a residential facility. The aims of the program are to break the cycle of hospital admission, reduce rates of self-harm, and support the complex Recovery journey of consumers with a diagnosis of borderline personality disorder. Open Borders provides an exemplar for other health service organisations seeking to establish Recovery-oriented crisis intervention alternatives.

DOI 10.1080/01612840.2016.1191565
Citations Scopus - 8Web of Science - 8
2016 Radermacher R, Srivastava S, Walsham M, Sao C, Paolucci F, 'Enhancing the Inclusion of Vulnerable and High-Risk Groups in Demand-Side Health Financing Schemes in Cambodia: A Concept for a Risk-Adjusted Subsidy Approach', Geneva Papers on Risk and Insurance: Issues and Practice, 41 244-258 (2016) [C1]

Efforts are currently under way in Cambodia to expand the population coverage of social health protection schemes (health equity funds and voluntary insurance). Aligning the benef... [more]

Efforts are currently under way in Cambodia to expand the population coverage of social health protection schemes (health equity funds and voluntary insurance). Aligning the benefit packages for members of such schemes poses particular challenges in relation to the insurance component, as the financing of direct benefits in the insurance relies largely on the collection of voluntary premiums. This paper develops the concept of a targeted "risk-adjusted subsidy" approach to address this issue. Data on the health-seeking behaviour of insured households from Kampong Thom district over the course of one year (2010) are used to illustrate the concept. To retain the currently applied community rating and set incentives for cost effectiveness in administrative costs, as well as to avoid cream skimming (focusing on "good risks"), a risk-adjustment mechanism is proposed that would provide ex ante subsidies to insurance schemes according to the expected additional cost of a person joining the scheme. Although the concept is developed using the example of Cambodia, it is equally applicable to all developing countries facing fragmented risk pools while aiming for universal health coverage.

DOI 10.1057/gpp.2016.5
Citations Scopus - 5Web of Science - 5
2016 Baji P, García-Goñi M, Gulácsi L, Mentzakis E, Paolucci F, 'Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries', European Journal of Health Economics, 17 791-799 (2016) [C1]

Background: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified... [more]

Background: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. Objective: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. Method: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N¿=¿153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. Results: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. Conclusion: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.

DOI 10.1007/s10198-015-0721-x
Citations Scopus - 10Web of Science - 6
2015 Paolucci F, Sowa PM, Garcia-Goni M, Ergas H, 'Mandatory aged care insurance: a case for Australia', AGEING & SOCIETY, 35 231-245 (2015)
DOI 10.1017/S0144686X13000767
Citations Scopus - 3Web of Science - 2
2015 Paolucci F, Mentzakis E, Defechereux T, Niessen LW, 'Equity and efficiency preferences of health policy makers in China - A stated preference analysis', Health Policy and Planning, 30 1059-1066 (2015)

Background Macroeconomic growth in China enables significant progress in health care and public health. It faces difficult choices regarding access, quality and affordability, whi... [more]

Background Macroeconomic growth in China enables significant progress in health care and public health. It faces difficult choices regarding access, quality and affordability, while dealing with the increasing burden of chronic diseases. Policymakers are pressured to make complex decisions while implementing health strategies. This study shows how this process could be structured and reports the specific equity and efficiency preferences among Chinese policymakers. Methods In total, 78 regional, provincial and national level policymakers with considerable experience participated in a discrete choice experiment, weighting the relative importance of six policy attributes describing equity and efficiency. Results from a conditional logistic model are presented for the six criteria, measuring the associated weights. Observed and unobserved heterogeneities were incorporated and tested in the model. Findings are used to give an example of ranking health interventions in relation to the present disease burden in China. Results In general, respondents showed strong preference for efficiency criteria i.e. total beneficiaries and cost-effectiveness as the most important attributes in decision making over equity criteria. Hence, priority interventions would be those conditions that are most prevalent in the country and cost least per health gain. Conclusion Although efficiency criteria override equity ones, major health threats in China would be targeted. Multicriteria decision analysis makes explicit important trade-offs between efficiency and equity, leading to explicit, transparent and rational policy making.

DOI 10.1093/heapol/czu123
Citations Scopus - 20Web of Science - 15
2015 Bakx P, Chernichovsky D, Paolucci F, Schokkaert E, Trottmann M, Wasem J, Schut F, 'Demand-side strategies to deal with moral hazard in public insurance for long-term care', Journal of Health Services Research and Policy, 20 170-176 (2015)

Moral hazard in public insurance for long-term care may be counteracted by strategies influencing supply or demand. Demand-side strategies may target the patient or the insurer. V... [more]

Moral hazard in public insurance for long-term care may be counteracted by strategies influencing supply or demand. Demand-side strategies may target the patient or the insurer. Various demand-side strategies and how they are implemented in four European countries (Germany, Belgium, Switzerland and the Netherlands) are described, highlighting the pros and cons of each strategy. Patient-oriented strategies to counteract moral hazard are used in all four countries but their impact on efficiency is unclear and crucially depends on their design. Strategies targeted at insurers are much less popular: Belgium and Switzerland have introduced elements of managed competition for some types of long-term care, as has the Netherlands in 2015. As only some elements of managed competition have been introduced, it is unclear whether it improves efficiency. Its effect will depend on the feasibility of setting appropriate financial incentives for insurers using risk equalization and the willingness of governments to provide insurers with instruments to manage long-term care.

DOI 10.1177/1355819615575080
Citations Scopus - 13Web of Science - 11
2015 García-Goñi M, Nuño-Solinís R, Orueta JF, Paolucci F, 'Is utilization of health services for HIV patients equal by socioeconomic status? Evidence from the Basque country', International Journal for Equity in Health, 14 (2015)

Introduction: Access to ART and health services is guaranteed under universal coverage to improve life expectancy and quality of life for HIV patients. However, it remains unknown... [more]

Introduction: Access to ART and health services is guaranteed under universal coverage to improve life expectancy and quality of life for HIV patients. However, it remains unknown whether patients of different socioeconomic background equally use different types of health services. Methods: We use one-year (2010-2011) data on individual healthcare utilization and expenditures for the total population (N = 2262698) of the Basque Country. We observe the prevalence of HIV and use OLS regressions to estimate the impact on health utilization of demographic, socioeconomic characteristics, and health status in such patients. Results: HIV prevalence per 1000 individuals is greater the lower the socioeconomic status (0.784 for highest; 2.135 for lowest), for males (1.616) versus females (0.729), and for middle-age groups (26-45 and 46-65). Health expenditures are 11826¿ greater for HIV patients than for others, but with differences by socioeconomic group derived from a different mix of services utilization (total cost of 13058¿ for poorest, 14960¿ for richest). Controlling for health status and demographic variables, poor HIV patients consume more on pharmaceuticals; rich in specialists and hospital care. Therefore, there is inequity in health services utilization by socioeconomic groups. Conclusions: Equity in health provision for HIV patients represents a challenge even if access to treatment is guaranteed. Lack of information in poorer individuals might lead to under-provision while richer individuals might demand over-provision. We recommend establishing accurate clinical guidelines with the appropriate mix of health provision by validated need for all socioeconomic groups; promoting educational programs so that patients demand the appropriate mix of services, and stimulating integrated care for HIV patients with multiple chronic conditions.

DOI 10.1186/s12939-015-0215-6
Citations Scopus - 4Web of Science - 3
2014 Mentzakis E, Paolucci F, Rubicko G, 'Priority Setting in the Austrian Healthcare System: Results from a Discrete Choice Experiment and Implications for Mental Health', JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 17 61-73 (2014)
Citations Scopus - 10Web of Science - 7
2014 Orueta JF, Garcia-Alvarez A, Garcia-Goni M, Paolucci F, Nuno-Solinis R, 'Prevalence and Costs of Multimorbidity by Deprivation Levels in the Basque Country: A Population Based Study Using Health Administrative Databases', PLOS ONE, 9 (2014)
DOI 10.1371/journal.pone.0089787
Citations Scopus - 56Web of Science - 48
2014 García-Goñi M, Paolucci F, 'The Development of an Aged Care Insurance Market in Spain', Geneva Association Health and Ageing Newsletter, 30 (2014)
2013 Sowa PM, Stoelwinder JU, Paolucci F, 'Improving risk equalisation in health insurance markets: lessons from the Australian model', The Geneva Association Health and Ageing Newsletter, 29 (2013)
2013 Goñi-García M, Hernández-Quevedo C, Nuño-Solinís R, Paolucci F, 'Is Spain s NHS evolving to a high-performing chronic health system?', Eurohealth, 19 41-43 (2013)
2013 Tanios N, Wagner M, Tony M, Baltussen R, van Til J, Rindress D, et al., 'Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers.', Int J Technol Assess Health Care, 29 456-465 (2013)
DOI 10.1017/S0266462313000573
Citations Web of Science - 62
2013 Sowa PM, Butler JRG, Connelly L, Paolucci F, 'Health-care accessibility in seven countries in eastern Europe: a multinomial logit study of individual unmet medical needs', LANCET, 381 135-135 (2013)
Citations Web of Science - 1
2012 Garcia-Goni M, Hernandez-Quevedo C, Nuno-Solinis R, Paolucci F, 'Pathways towards chronic care-focused healthcare systems: Evidence from Spain', HEALTH POLICY, 108 236-245 (2012)
DOI 10.1016/j.healthpol.2012.09.014
Citations Scopus - 31Web of Science - 28
2012 Robson A, Paolucci F, 'Private Health Insurance Incentives in Australia: The Effects of Recent Changes to Price Carrots and Income Sticks', GENEVA PAPERS ON RISK AND INSURANCE-ISSUES AND PRACTICE, 37 725-744 (2012)
DOI 10.1057/gpp.2012.38
Citations Scopus - 9Web of Science - 8
2012 Mirelman A, Mentzakis E, Kinter E, Paolucci F, Fordham R, Ozawa S, et al., 'Decision-making criteria among national policymakers in five countries: A discrete choice experiment eliciting relative preferences for equity and efficiency', Value in Health, 15 534-539 (2012)

Background: Worldwide, there is a need for formalization of the priority setting processes in health. Recent research has used the term multicriteria decision analysis for methods... [more]

Background: Worldwide, there is a need for formalization of the priority setting processes in health. Recent research has used the term multicriteria decision analysis for methods that systematically include preferences for both equity and efficiency. The present study compares decision-makers' preferences at the country level for a set of equity and efficiency criteria according to a multicriteria decision analysis framework. Methods: Discrete choice experiments were conducted for Brazil, Cuba, Nepal, Norway, and Uganda. By using standardized methods, we elicited preferences for intervention attributes using a individual choice questionnaire. A multinomial logistic regression was applied to estimate the coefficients for all single-policy criteria, per country. Attributes were assigned to an equity group or to an efficiency group. After testing for scale variance, predicted probabilities for interventions with both types of attributes were compared across countries. Results: The Norway and Nepal groups showed considerable preferences for efficiency criteria over equity criteria with percent change in respective predicted sum probabilities of [10%, -84%] and [6%, -79%]. Brazil and Uganda also showed preference for the efficiency criteria though less convincingly ([-34%, -93%], [-18%, -63%], respectively). The Cuban group showed the strongest preferences with equity attributes dominating efficiency ([-52%, 213%]). Conclusions: Group preferences of policymakers show explicit but varying trade-offs of efficiency and equity in these diverse settings. This multicriteria decision analysis approach, using discrete choice experiments, indicates that systematic setting of health priorities is possible across a variety of countries. It may be a valuable tool to guide health reform initiatives. © 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

DOI 10.1016/j.jval.2012.04.001
Citations Scopus - 52Web of Science - 42
2012 Defechereux T, Paolucci F, Mirelman A, Youngkong S, Botten G, Hagen TP, Niessen LW, 'Health care priority setting in Norway a multicriteria decision analysis', BMC Health Services Research, 12 (2012)

Background: Priority setting in population health is increasingly based on explicitly formulated values. The Patients Rights Act of the Norwegian tax-based health service guaranti... [more]

Background: Priority setting in population health is increasingly based on explicitly formulated values. The Patients Rights Act of the Norwegian tax-based health service guaranties all citizens health care in case of a severe illness, a proven health benefit, and proportionality between need and treatment. This study compares the values of the country's health policy makers with these three official principles. Methods. In total 34 policy makers participated in a discrete choice experiment, weighting the relative value of six policy criteria. We used multi-variate logistic regression with selection as dependent valuable to derive odds ratios for each criterion. Next, we constructed a composite league table - based on the sum score for the probability of selection - to rank potential interventions in five major disease areas. Results: The group considered cost effectiveness, large individual benefits and severity of disease as the most important criteria in decision making. Priority interventions are those related to cardiovascular diseases and respiratory diseases. Less attractive interventions rank those related to mental health. Conclusions: Norwegian policy makers' values are in agreement with principles formulated in national health laws. Multi-criteria decision approaches may provide a tool to support explicit allocation decisions. © 2012 Defechereux et al; licensee BioMed Central Ltd.

DOI 10.1186/1472-6963-12-39
Citations Scopus - 62Web of Science - 46
2012 Paolucci F, Garcia-Goni M, Defechereux T, Mentzakis E, 'Evaluating preferences for equity and efficiency among national health policy makers in Spain', EUROPEAN JOURNAL OF PUBLIC HEALTH, 22 152-153 (2012)
2012 Garcia-Goni M, Paolucci F, Mcrea I, Livilenko L, 'The evolution towards chronic care-focused healthcare systems. An international perspective', EUROPEAN JOURNAL OF PUBLIC HEALTH, 22 246-246 (2012)
2012 García-Goñi M, Hernández-Quevedo C, Nuño-Solinís R, Paolucci F, Paolucci F, 'Verso sistemi sanitari orientati alle patologie croniche: il caso spagnolo. Politiche Sanitarie', Politiche Sanitarie, 13 160-171 (2012)
DOI 10.1706/1184.13101
2012 Paolucci F, James B, Wynand VDV, Wynand VDV, 'Mix pubblico e privato nel finanziamento dei servizi sanitari in Australia: opt-out con sussidi aggiustati per il profilo di rischio degli assicurati?', Politiche Sanitarie, 13 147-159 (2012)
DOI 10.1706/1184.13100
2011 McRae IS, Paolucci F, 'The global financial crisis and Australian general practice', Australian Health Review, 35 32-35 (2011)

Objective. To explore the potential effects of the global financial crisis (GFC) on the market for general practitioner (GP) services in Australia. Design. We estimate the impact ... [more]

Objective. To explore the potential effects of the global financial crisis (GFC) on the market for general practitioner (GP) services in Australia. Design. We estimate the impact of changes in unemployment rates on demand for GP services and the impact of lost asset values on GP retirement plans and work patterns. Combining these supply and demand effects, we estimate the potential effect of the GFC on the market for GP services under various scenarios. Results. If deferral of retirement increases GP availability by 2%, and historic trends to reduce GP working hours are halved, at the current level of ~5.2% unemployment average fees would decline by $0.23 per GP consultation and volumes of GP services would rise by 2.53% with almost no change in average GP gross earnings over what would otherwise have occurred. With 8.5% unemployment, as initially predicted by Treasury, GP fees would increase by $0.91 and GP income by nearly 3%. Conclusions. The GFC is likely to increase activity in the GP market and potentially to reduce fee levels relative to the pre-GFC trends. Net effects on average GP incomes are likely to be small at current unemployment levels. What is known about the topic? Although the broad directions of the impact of the global financial crisis on the demand for and supply of GP services have been the subject of public discussion, the overall impact on the GP market has not been formally assessed. What does this paper add? Drawing on existing supply and demand models, we estimate the likely effect of the global financial crisis on GP activity levels, GP earnings, and the fees to be faced by patients. What are the implications for practitioners? Practitioners on average are likely to work harder to recover losses in the investments they have made for their retirements. They may face lower fees than would have been the case due to the increasing supply of GPs as some defer retirement, but average incomes are likely to be minimally affected. © 2011 AHHA.

DOI 10.1071/AH09830
Citations Scopus - 9Web of Science - 7
2011 Strazdins L, Griffin AL, Broom DH, Banwell C, Korda R, Dixon J, et al., 'Time scarcity: Another health inequality?', Environment and Planning A, 43 545-559 (2011)

Considerable policy action has focused on the social patterning of health, especially the health risks associated with low income. More recent attention has turned to transport, f... [more]

Considerable policy action has focused on the social patterning of health, especially the health risks associated with low income. More recent attention has turned to transport, food systems, workplaces, and location, and the way their intersections with social position and income create health inequalities. Time is another dimension that structures what people do; yet the way in which time contours health has been neglected. This paper explores (a) how time might influence health, and (b) the way in which time scarcity complicates current understandings of health inequalities. Alongside other meanings, time can be thought of as a health resource. People need time to access health services, build close relationships, exercise, work, play, care, and consume-all activities that are fundamental to health. There is evidence that the experience of time pressure is directly related to poorer mental health. Lack of time is also the main reason people give for not taking exercise or eating healthy food. Thus, another impact of time scarcity may be its prevention of activities and behaviours critical for good health. We investigate whether time scarcity, like financial pressure, is socially patterned, and thus likely to generate health inequality. The experience of time scarcity appears to be linked to variations in time devoted to employment or caring-activities closely bound to gender, status, and life course. One reason that time scarcity is socially patterned is because of the way in which caring is valued, allocated, and negotiated in households and the market. Adding paid employment to caring workloads is now normative, transforming the allocation of time within families. But caring requires a close interlocking with others' needs, which are often urgent and unpredictable, creating conflict with the linear, scheduled, and commodified approach to time required in the workplace. We review the evidence for the possibility that these time pressures are indeed contributing to socially patterned health inequalities among people caring for others. We also explore the potential for time scarcity to compound other sources of health inequality through interplays with income and space (urban form, transportation networks and place of residence). People who are both time and income poor, such as lone mothers, may face compounding barriers to good health, and the urban geography of time-scarce families represents the embedding of time - money - space trade-offs linked to physical location. In Australia and the US, poorer families are more likely to live in mid to outer suburbs, necessitating longer commutes to work. These suburbs have inferior public transport access, and can lack goods and services essential to health such as shops selling fresh foods. We conclude with a tentative framework for considering time and health in the context of policy actions. For example, social policy efforts to increase workforce participation may be economically necessary, but could have time-related consequences that alter health. Similarly, if cities are to be made livable, health promoting, and more equitable, urban designers need to understand time and time - income - space trade-offs. Indeed, many social policies and planning and health interventions involve time dimensions which, if they remain unacknowledged, could further compound time pressures and time-related health inequality. © 2011 Pion Ltd and its Licensors.

DOI 10.1068/a4360
Citations Scopus - 120Web of Science - 103
2011 Ergas H, Paolucci F, 'Providing and financing aged care in Australia', Risk Management and Healthcare Policy, 4 67-80 (2011)

This article focuses on the provision and financing of aged care in Australia. Demand for aged care will increase substantially as a result of population aging, with the number of... [more]

This article focuses on the provision and financing of aged care in Australia. Demand for aged care will increase substantially as a result of population aging, with the number of Australians aged 85 and over projected to increase from 400,000 in 2010 to over 1.8 million in 2051. Meeting this demand will greatly strain the current system, and makes it important to exploit opportunities for increased efficiency. A move to greater beneficiary co-payments is also likely, though its extent may depend on whether aged care insurance and other forms of pre-payment can develop.

DOI 10.2147/RMHP.S16718
Citations Scopus - 8
2011 Paolucci F, Sowa PM, 'Incentives and Choice in Healthcare', ECONOMIC RECORD, 87 174-176 (2011)
DOI 10.1111/j.1475-4932.2010.00715.x
2011 Robson A, Ergas H, Paolucci F, Paolucci F, 'The Analytics of the Australian Private Health Insurance Rebate and the Medicare Levy Surcharge', Agenda: a journal of policy analysis and reform, (2011)
2011 Paolucci F, Butler JRG, van de Ven WPMM, Ven WPMMVD, 'Removing Duplication in Public/Private Health Insurance in Australia: Opting Out With Risk-adjusted Subsidies?', Agenda: a journal of policy analysis and reform, 18 49-70 (2011)
2011 Paolucci F, Shmueli A, Shmueli A, 'The Introduction of Ex-ante Risk Equalisation in the Australian Private Health Insurance Market: A First Step', Agenda: a journal of policy analysis and reform, 18 71-92 (2011)
2010 Baltussen R, Youngkong S, Paolucci F, Niessen L, 'Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences', Health Policy, 96 262-264 (2010)

This paper capitalizes on a first set of experiences on the application of multi-criteria decision analysis (MCDA) in seven low- and middle-income settings. It thereby reacts to a... [more]

This paper capitalizes on a first set of experiences on the application of multi-criteria decision analysis (MCDA) in seven low- and middle-income settings. It thereby reacts to a recent paper by Peacock et al., highlighting the potential of MCDA to guide policy makers in highly specific decision-making contexts. We argue that MCDA also has a broader application in setting priorities in health, i.e. to indicate general perceptions on priorities without defining the allocation of resources in a precise fashion. This use of MCDA can have far-reaching and constructive influences on policy formulation. © 2010 Elsevier Ireland Ltd.

DOI 10.1016/j.healthpol.2010.01.009
Citations Scopus - 69Web of Science - 53
2010 Connelly LB, Paolucci F, Butler JRG, Collins P, 'Risk equalisation and voluntary health insurance markets: The case of Australia', Health Policy, 98 3-14 (2010)

In April 2007, Australia introduced a risk equalisation (RE) scheme (de facto a claims equalisation scheme), which replaced an extant reinsurance scheme that had operated since 19... [more]

In April 2007, Australia introduced a risk equalisation (RE) scheme (de facto a claims equalisation scheme), which replaced an extant reinsurance scheme that had operated since 1976. This scheme is one of a number of policy measures that the Australian Government has instituted to support the voluntary private health insurance (PHI) market which is subject to mandatory community rating and the attendant problem of selection. The latter has been a persistent concern in the Australian PHI market since the introduction of Australia's universal, compulsory national health insurance scheme Medicare. This paper presents a brief overview of Australia's health care financing arrangements and, in particular, focuses on the history, structure and functioning of the RE scheme. It provides an exposition of the operation of the scheme and empirical evidence of the scheme's effects in its first full year of operation, 2007-08. The paper makes three contributions: first, it provides the only detailed overview of the functioning of the Australian RE scheme published to date; second, it presents the first empirical measures of the scheme's operation at the level of the 38 individual PHI funds; and third, it describes the systematic differences in the scheme's operation with respect to large and small funds. Thus, this paper provides a number of insights into the operation and outcomes of the Australian RE scheme following its first year of operation. © 2010.

DOI 10.1016/j.healthpol.2010.06.002
Citations Scopus - 16Web of Science - 13
2010 Armstrong J, Paolucci F, McLeod H, van de Ven WPMM, 'Risk equalisation in voluntary health insurance markets: A three country comparison', Health Policy, 98 39-49 (2010)

The paper summarises the conclusions for health policy from the experience of three countries who have introduced risk equalisation subsidies, in their voluntary health insurance ... [more]

The paper summarises the conclusions for health policy from the experience of three countries who have introduced risk equalisation subsidies, in their voluntary health insurance (VHI) markets. The countries chosen are Australia, Ireland and South Africa. All of these countries have developed VHI markets and have progressed towards introducing risk equalisation. The objective of such subsidies is primarily to make VHI affordable while encouraging efficiency in health care production.The paper presents a conceptual framework to understand and compare risk equalisation subsidies in VHI markets. The paper outlines how such subsidies are organised in each of the countries and identifies problems that arise in their implementation.We conclude that the objectives of risk equalisation, in VHI markets are no different to those in countries with mandatory insurance systems. We find that the introduction of risk equalisation subsidies is complex and that countries seeking to introduce risk equalisation in VHI markets must carefully consider how such subsidies advance their overall health policy goals. Furthermore, we conclude that such subsidies must be structured correctly as otherwise incentives exist for risk selection which may threaten affordability and efficiency.Our overall conclusion is that also in voluntary health insurance markets risk equalisation has a role in meeting the related public policy objectives of risk solidarity and affordability, and without it these objectives are severely undermined. © 2010 Elsevier Ireland Ltd.

DOI 10.1016/j.healthpol.2010.06.009
Citations Scopus - 16Web of Science - 12
2010 Armstrong J, Paolucci F, van de Ven WPMM, 'Risk equalisation in voluntary health insurance markets', Health Policy, 98 1-2 (2010)
DOI 10.1016/j.healthpol.2010.06.007
Citations Scopus - 2Web of Science - 4
2010 Armstrong J, Paolucci F, 'Risk equalisation in Ireland and Australia: A simulation analysis to compare outcomes', Geneva Papers on Risk and Insurance: Issues and Practice, 35 521-538 (2010)

Risk equalisation has been implemented in a number of countries as a means of providing explicit risk-adjusted transfers between health insurance undertakings to improve efficienc... [more]

Risk equalisation has been implemented in a number of countries as a means of providing explicit risk-adjusted transfers between health insurance undertakings to improve efficiency within the health insurance market, and make health insurance affordable. Two such countries are Australia and Ireland. In this article, a simulation exercise is carried out to compare the effectiveness of the two countries risk equalisation schemes in meeting the policy objectives of encouraging insurers to be efficient and discouraging them from engaging in risk selection. The results of the analysis show that the Australian scheme is less effective than the Irish scheme in reducing the incentive for risk selection and in encouraging insurers to be efficient. The results provide evidence that direct standardisation mechanisms (as used in Ireland) can lead to superior outcomes as compared to indirect standardisation mechanisms (as used in Australia) in terms of promoting efficiency and deterring risk selection. © 2010 The International Association for the Study of Insurance Economics.

DOI 10.1057/gpp.2010.23
Citations Scopus - 2Web of Science - 3
2010 Ergas H, Paolucci F, 'Providing and financing aged care in Australia', GENEVA ASSOCIATION INFORMATION NEWSLETTER HEALTH AND AGEING, 23 (2010)
2010 Rebba V, Paolucci F, Paolucci F, 'Presente e futuro dei sistemi di long-term care: un confronto tra Italia, Germania, Paesi Bassi e Australia.', Politiche Sanitarie, 11 (2010)
2010 Paolucci F, Henry E, Henry E, 'L erogazione e il finanziamento dell assistenza agli anziani in Australia', Politiche Sanitarie, 11 12-24 (2010)
DOI 10.1706/521.6242
2009 Stoelwinder JU, Paolucci F, 'Sustaining medicare through consumer choice of health funds: Lessons from the Netherlands', Medical Journal of Australia, 191 30-32 (2009)

¿ The current escalation in costs of Australia's health care system does not appear to be sustainable. ¿ Sustainable financing requires direct engagement of consumers - inste... [more]

¿ The current escalation in costs of Australia's health care system does not appear to be sustainable. ¿ Sustainable financing requires direct engagement of consumers - instead of the current political process driven by special interest groups, targeted at gaining a larger share of the federal and state governments' budgets. ¿ Reforms in the Netherlands, directed at achieving universal insurance with consumer choice of health fund, provide valuable lessons for Australia on how to design sustainable financing.

DOI 10.5694/j.1326-5377.2009.tb02671.x
Citations Scopus - 6Web of Science - 5
2009 Paolucci F, Prinsze F, Stam PJA, van de Ven WPMM, 'The potential premium range of risk-rating in competitive markets for supplementary health insurance', International Journal of Health Care Finance and Economics, 9 243-258 (2009)

In this paper, we simulate several scenarios of the potential premium range for voluntary (supplementary) health insurance, covering benefits which might be excluded from mandator... [more]

In this paper, we simulate several scenarios of the potential premium range for voluntary (supplementary) health insurance, covering benefits which might be excluded from mandatory health insurance (MI). Our findings show that, by adding risk-factors, the minimum premium decreases and the maximum increases. The magnitude of the premium range is especially substantial for benefits such as medical devices and drugs. When removing benefits from MI policymakers should be aware of the implications for the potential reduction of affordability of voluntary health insurance coverage in a competitive market. © Springer Science+Business Media, LLC 2009.

DOI 10.1007/s10754-008-9049-8
Citations Scopus - 3Web of Science - 4
2007 Paolucci F, Schut E, Beck K, Greß S, Van de Voorde C, Zmora I, 'Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets', Health Economics, Policy and Law, 2 173-192 (2007)

As the share of supplementary health insurance (SI) in health care finance is likely to grow, SI may become an increasingly attractive tool for risk-selection in basic health insu... [more]

As the share of supplementary health insurance (SI) in health care finance is likely to grow, SI may become an increasingly attractive tool for risk-selection in basic health insurance (BI). In this paper, we develop a conceptual framework to assess the probability that insurers will use SI for favourable risk-selection in BI. We apply our framework to five countries in which risk-selection via SI is feasible: Belgium, Germany, Israel, the Netherlands, and Switzerland. For each country, we review the available evidence of SI being used as selection device. We find that the probability that SI is and will be used for risk-selection substantially varies across countries. Finally, we discuss several strategies for policy makers to reduce the chance that SI will be used for risk-selection in BI markets. © 2006 Cambridge University Press.

DOI 10.1017/S1744133107004124
Citations Scopus - 27Web of Science - 25
2006 Paolucci F, Den Exter A, Van de Ven WPMM, 'Solidarity in competitive health insurance markets: analysing the relevant EC legal framework.', Health economics, policy, and law, 1 107-126 (2006)

In this article we perform an economic analysis of different regulatory frameworks that aim at guaranteeing solidarity in competitive health insurance markets. Thereafter, we anal... [more]

In this article we perform an economic analysis of different regulatory frameworks that aim at guaranteeing solidarity in competitive health insurance markets. Thereafter, we analyse the legal conformity of these intervention strategies with EC law. We find that risk compensation schemes are the first-best intervention strategy because they guarantee an 'acceptable level of solidarity' without hindering free trade and competition and without reducing efficiency. Second-best options are premium and excess-loss compensation schemes, which guarantee solidarity at the expense of some efficiency. Premium rate restrictions and open enrolment should be avoided because they reduce efficiency and are unnecessary, not proportional, and undesirable to the pursuit of the general good. These conclusions are relevant for EU countries that adopt premium rate restrictions and open enrolment in combination with a risk compensation scheme, such as Ireland and the Netherlands. In these countries policy makers should design the health insurance schemes in conformity with EC law, for example by replacing premium rate restrictions and open enrolment with premium and/or excess-loss compensation schemes.

DOI 10.1017/S1744133105000137
Citations Scopus - 20Web of Science - 15
2005 Masseria C, Paolucci F, 'Equity in the delivery of inpatient care in Europe and Italy', Quaderni ACP, 12 3-7 (2005)

Income-related horizontal inequity in hospital admissions is estimated in twelve European countries. Pooled data of the EHCS for five years (1994-1998) are used to estimate and co... [more]

Income-related horizontal inequity in hospital admissions is estimated in twelve European countries. Pooled data of the EHCS for five years (1994-1998) are used to estimate and compare inequity indices. In most EU member states, after standardizing for need differences, the better off are more likely to be admitted to hospitals than the poor, and significantly so in Portugal, Greece, Austria, Italy, Ireland, Germany and France. Regional disparities in hospital supply also plays a role in the measured degree of inequity, in particular, in Italy and Spain. For the former we studied more deeply this phenomenon by using the Multiscopo ISTAT survey. The analysis confirms that people living in the North of Italy have a higher probability of being hospitalized than their counterparts and enjoy better quality of care. To make it worse, in the South people tend more intensively to move to other regions to receive hospital care.

Citations Scopus - 1
Show 88 more journal articles

Conference (2 outputs)

Year Citation Altmetrics Link
2022 Fuentes GLH, Forrester S, Foster J, Ryan N, Carter H, Kennedy M, et al., 'Analysis and lessons learnt about the implementation of the SISTAQUIT smoking cessation trial in pregnant Aboriginal and Torres Strait Islander women', DRUG AND ALCOHOL REVIEW (2022)
2012 Paolucci F, 'Medicare Select': a pathway towards competitive social health insurance in Australia', Jerusalem (2012)

Media (32 outputs)

Year Citation Altmetrics Link
2020 Paolucci F, Melia A, Lee D, Mahmoudi N, 'Is aggressive hotel isolation worth the cost to fight COVID-19? The answer depends on family size', (2020)
Co-authors Adrian Melia
2020 Paolucci F, 'Radio interview - Channel News Asia (CNA)', (2020)
2020 Higginson S, Paolucci F, 'Health induced economic crisis in Australia: One size doesn t fit all.', (2020)
2020 Paolucci F, 'Radio interview - ABCDrive', (2020)
2020 Henriquez J, Garcia Goñi M, Paolucci F, 'The COVID-19 catastrophe in Spain', (2020)
2020 Moy N, Paolucci F, 'While UK COVID-19 cases rose, Australia's slowed to a halt.', (2020)
2020 Antonini M, Berardi C, Paolucci F, 'Le Regioni in ordine sparso nella lotta al Covid', (2020)
2020 Paolucci F, 'Interview - ABC NewsRadio', (2020)
2020 Antonini M, Berardi C, Paolucci F, 'What Australia can learn from Italy s response to the COVID-19 disease', (2020)
2020 Berardi C, Antonini M, Paolucci F, 'How the coronavirus crippled Italy', (2020)
2020 Paolucci F, 'Radio interview - ABC NewsRadio', (2020)
2020 Paolucci F, 'Radio interview - CNA938', (2020)
2020 Antonini M, Berardi C, Paolucci F, 'Il pendolo del Covid-19, tra salute pubblica ed economia', (2020)
2020 Moy N, Paolucci F, 'Restructuring higher education funding in Australia during a pandemic', (2020)
2020 Paolucci F, Lee D, Wall L, Hinwood M, Antonini M, 'A $200 fine for not wearing a mask is fair, as long as free masks go to those in need', (2020)
Co-authors Madeleine Hinwood, Laura Wall
2020 Benitez A, Velasco C, Paolucci F, 'Second wave of COVID-19: Lessons from Latin America', (2020)
2020 Milovanovic K, Higginson S, Paolucci F, 'Second wave lockdowns with risk-targeted policy responses', (2020)
2019 Paolucci F, 'Isapres 5 puntos para avanzar', (2019)
2019 Paolucci F, Melia A, Henriquez J, 'Private health insurance premiums should be based on age and health status', (2019)
Co-authors Adrian Melia
2019 Paolucci F, 'Inflación de prima GES', (2019)
2019 Paolucci F, 'Making private insurance attractive again', (2019)
2015 Paolucci F, 'Allow Aussies to opt out of Medicare and rely on private insurance', (2015)
2015 Paolucci F, 'Radio Interview - ABC', (2015)
2015 Paolucci F, 'Policies: Paying the premium', (2015)
2015 Paolucci F, 'Radio interview - Dubai Eye 103.8', (2015)
2015 Paolucci F, 'Want real health reform? Integrate public and private health into one mandatory insurance system', (2015)
2015 Paolucci F, 'Assessing the roll-out of Dubai s Health Insurance Scheme', (2015)
2013 Paolucci F, 'Radio Interview - SBS', (2013)
2012 Paolucci F, 'Radio interview - SBS', (2012)
2011 Paolucci F, 'Radio Interview - SBS', (2011)
2011 Paolucci F, 'Radio interview - SBS', (2011)
2008 Paolucci F, 'The opportunity to opt-out of Medicare', (2008)
Show 29 more medias

Other (9 outputs)

Year Citation Altmetrics Link
2020 Henriquez J, Gonzalo Almorox E, Garcia-Goni M, Paolucci F, 'First Months of the COVID-19 Pandemic in Spain', (2020)
DOI 10.2139/ssrn.3659377
2020 Fouda A, Mahmoudi N, Moy N, Paolucci F, 'Comparing the COVID-19 Pandemic in Greece, Iceland, New Zealand, and Singapore', : SSRN (2020)
DOI 10.2139/ssrn.3658463
2020 Milovanovic K, Higginson S, Gillespie J, Wall L, Moy N, Hinwood M, et al., 'COVID-19: The Need for an Australian Economic Pandemic Response Plan', : SSRN (2020)
DOI 10.2139/ssrn.3663929
Co-authors Christopher M Williams, Laura Wall, Madeleine Hinwood
2020 Benitez A, Velasco C, Sequeira AR, Henriquez J, Menezes F, Paolucci F, 'Responses to COVID-19 in Five Countries of Latin America', : SSRN (2020)
DOI 10.2139/ssrn.3663292
2020 Moy N, Antonini M, Kyhlstedt M, Paolucci F, 'Categorising Policy & Technology Interventions for a Pandemic: A Comparative and Conceptual Framework', : SSRN (2020)
2016 Henríquez J, Velasco C, Mentzakis E, Paolucci F, 'Más equidad y eficiencia en Isapres: Evaluación y propuestas al mecanismo de compensación de riesgos.', : Centro de Estudios Publicos (2016)
2015 Paolucci F, García-Goni M, ni MG-G, 'The case for change towards universal and sustainable national health insurance and financing for Australia: enabling the transition to a chronic condition focussed health care system', (2015)
2011 García-Goñi M, Hernandez-Quevedo C, Paolucci F, Nuño-Solinís R, 'Roadmap towards chronic-based healthcare systems: the case of Spain', : London School of Economics (2011)
2009 van Exel J, Brouwer W, Paolucci F, 'Grensoverschrijdende zorg: Redenen om te gaan of te blijven.', (2009)
Show 6 more others

Presentation (2 outputs)

Year Citation Altmetrics Link
2020 Paolucci F, 'Estrategias para enfrentar el COVID-19 y algunos aprendizajes. Los casos de Australia, Italia, Nueva Zelanda y Suecia', (2020)
2020 Paolucci F, 'What Have We Learned From this Crisis?', (2020)
Edit

Grants and Funding

Summary

Number of grants 52
Total funding $37,523,342

Click on a grant title below to expand the full details for that specific grant.


20235 grants / $5,831,969

Biomarker-based Diagnostic Toolkit to Personalize Pharmacological Approached in Congestive Heart Failure (BIOTOOL-CHF) Project$2,600,000

Funding body: European Commission, European Union

Funding body European Commission, European Union
Project Team

Marwa Atef, Francesco Paolucci

Scheme Research Grant
Role Lead
Funding Start 2023
Funding Finish 2025
GNo
Type Of Funding External
Category EXTE
UON N

The effectiveness of the regulatory settings for the Medicare Levy Surcharge (MLS), Rebate, and Lifetime Health Cover (LHC)$2,300,000

Funding body: Industry funded

Funding body Industry funded
Project Team

Richard van Kleef, Thomas McGuire, Emmanouil Mentzakis, Francesco Paolucci, Josefa Henriquez, Jacob Glazer

Scheme Industry Consulting Grant
Role Investigator
Funding Start 2023
Funding Finish 2023
GNo
Type Of Funding External
Category EXTE
UON N

MandEval: effectiveness and consequences of Australia's COVID-19 vaccine mandates$808,440

Funding body: Department of Health and Aged Care

Funding body Department of Health and Aged Care
Project Team

Doctor Mesfin Genie, Professor Francesco Paolucci

Scheme MRFF - Early to Mid-Career Researchers
Role Investigator
Funding Start 2023
Funding Finish 2025
GNo
Type Of Funding C1300 - Aust Competitive - Medical Research Future Fund
Category 1300
UON N

PhD Industry Scholarship in Health Analytics$109,893

Funding body: Honeysuckle Health Pty Limited

Funding body Honeysuckle Health Pty Limited
Project Team Professor Francesco Paolucci, Mr Stefano Bruzzo
Scheme PhD Scholarship
Role Lead
Funding Start 2023
Funding Finish 2026
GNo G2300293
Type Of Funding C3100 – Aust For Profit
Category 3100
UON Y

Private Health Insurance – Offset and Impact of Subsidies and Surcharges$13,636

Funding body: Finity Consulting Pty Limited

Funding body Finity Consulting Pty Limited
Project Team Professor Francesco Paolucci, Mr Andrew Matthews, Doctor Adrian Melia, Doctor Anh Pham
Scheme Research Grant
Role Lead
Funding Start 2023
Funding Finish 2024
GNo G2300944
Type Of Funding C3100 – Aust For Profit
Category 3100
UON Y

202213 grants / $6,766,531

Old and lonely? Preferences for peer support interventions among older adults in Australia$5,000,000

Funding body: Australian Commonwealth Government

Funding body Australian Commonwealth Government
Project Team

Francesco Paolucci

Scheme Research Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding C2120 - Aust Commonwealth - Other
Category 2120
UON N

National Heart Foundation Mental Health and Heart Disease Strategic Grant $964,531

Funding body: National Heart Foundation of Australia

Funding body National Heart Foundation of Australia
Scheme Mental Health and Heart Disease Strategic Grant
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding External
Category EXTE
UON N

Equity in Health and Wellbeing Program$412,000

Funding body: HMRI

Funding body HMRI
Scheme HMRI Equity in Health and Wellbeing Research Seed Grant
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding External
Category EXTE
UON N

The COVID-19 Vaccine Preferences Project$285,000

Funding body: Multiple national and international sources

Funding body Multiple national and international sources
Project Team

Marcello Antonini, Francesco Paolucci

Scheme Research Grant
Role Lead
Funding Start 2022
Funding Finish 2023
GNo
Type Of Funding External
Category EXTE
UON N

Caregiver preferences and trade-offs for features of support programs for people with dementia: A discrete choice experiment$30,000

Funding body: AcCORD

Funding body AcCORD
Scheme Research Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding External
Category EXTE
UON N

Public preferences, trade-offs and hesitancy for the COVID-19 vaccines and related policy restrictions: an international investigation$25,000

Funding body: Cross-College Research Scheme

Funding body Cross-College Research Scheme
Scheme Cross-College Research Scheme
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Private Health Insurance – Offset and Impact of Subsidies and Surcharges$15,000

Funding body: College of Human and Social Futures | University of Newcastle

Funding body College of Human and Social Futures | University of Newcastle
Project Team

Prof Francesco Paolucci (lead), Dr Adrian Melia, Dr Anh Pham

Scheme CHSF - Matched Funding
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Clozapine Prescribing: Optimising service provision and governance, integration with other care providers and incorporating learnings from Covid-19 $10,000

Funding body: Central Coast Local Health District

Funding body Central Coast Local Health District
Project Team Professor Francesco Paolucci, Miss Zephanie Jordan, David Duerden, Dr Rachel Sheather-Reid, Anthony Critchley, Simon Hill
Scheme Research Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo G2200257
Type Of Funding C2300 – Aust StateTerritoryLocal – Own Purpose
Category 2300
UON Y

The Value of Virtual Care: A patient, clinician and equity centred cost$10,000

Funding body: College of Human and Social Futures | University of Newcastle

Funding body College of Human and Social Futures | University of Newcastle
Project Team

A/Prof Doowon Lee (lead), Prof Francesco Paolucci, Mr Michael DiRienzo (HNE Health)

Scheme CHSF - Pilot Research Scheme: Projects, Pivots, Partnerships
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Eliciting public preferences towards COVID-19 vaccines: is there a trade-off between carrots, sticks and blinders vis a vis hesitancy?$10,000

Vice Chancellor’s 2022 Seed Funding Round

Funding body: Murdoch University

Funding body Murdoch University
Scheme Divisional Research Grant
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding External
Category EXTE
UON N

Ownership Structure and Pension Fund Performance$5,000

Funding body: College of Human and Social Futures | University of Newcastle

Funding body College of Human and Social Futures | University of Newcastle
Project Team

Dr Adrian Melia (lead), Dr Anh Pham, Prof Francesco Paolucci

Scheme CHSF - Matched Funding
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Empowering frail older patients on discharge from hospital: A randomised controlled trial$0

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team

Francesco Paolucci

Scheme Project Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON N

Loneliness Social Isolation and Chronic Disease Management. Leaving no one behind: improving the wellbeing of social housing tenants$0

Funding body: TCR

Funding body TCR
Project Team

Francesco Paolucci

Scheme Research Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding External
Category EXTE
UON N

20215 grants / $367,414

Industry Matching Funds$110,000

Funding body: College of Human and Social Futures | University of Newcastle

Funding body College of Human and Social Futures | University of Newcastle
Scheme CHSF - Industry Matching Funds
Role Lead
Funding Start 2021
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Telehealth Research Initiative, Part A: Telehealth Evidence Synthesis Studies$103,351

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Christopher Williams, Emeritus Professor Julie Byles, Doctor Madeleine Hinwood, Professor Frances Kay-Lambkin, Professor Francesco Paolucci, Professor Kate Senior, Doctor Laura Wall, Professor Luke Wolfenden
Scheme Research Grant
Role Investigator
Funding Start 2021
Funding Finish 2022
GNo G2101410
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

College contribution towards a shared PhD stipend$14,300

Funding body: College of Human and Social Futures | University of Newcastle

Funding body College of Human and Social Futures | University of Newcastle
Scheme CHSF
Role Lead
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

College top up for a Research Assistant on an NHMRC-funded project$13,997

Funding body: College of Human and Social Futures | University of Newcastle

Funding body College of Human and Social Futures | University of Newcastle
Scheme CHSF
Role Lead
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

20203 grants / $1,247,944

A practice change intervention to increase the routine provision of care addressing gestational weight gain: a stepped-wedge trial$747,944

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor John Wiggers, Doctor Melanie Kingsland, Professor Karen Campbell, Professor Craig Pennell, Professor Luke Wolfenden, Professor Chris Rissel, Professor John Attia, Professor Maralyn Foureur, Professor Francesco Paolucci, Doctor Jenna Hollis, Professor Maralyn Foureur
Scheme Partnership Projects
Role Investigator
Funding Start 2020
Funding Finish 2023
GNo G1900839
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

A practice change intervention to increase the routine provision of care addressing gestational weight gain: a stepped-wedge trial$250,000

Funding body: Hunter New England Local Health District

Funding body Hunter New England Local Health District
Project Team Professor John Wiggers, Professor John Attia, Professor Karen Campbell, Professor Maralyn Foureur, Doctor Jenna Hollis, Doctor Melanie Kingsland, Professor Francesco Paolucci, Professor Craig Pennell, Professor Chris Rissel, Professor Luke Wolfenden
Scheme Partnership Projects Partner Funding
Role Investigator
Funding Start 2020
Funding Finish 2022
GNo G2000238
Type Of Funding C2400 – Aust StateTerritoryLocal – Other
Category 2400
UON Y

Child Dental Benefit Policies and the Health of Australian Children $250,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Scheme Discovery Projects
Role Investigator
Funding Start 2020
Funding Finish 2022
GNo
Type Of Funding C1200 - Aust Competitive - ARC
Category 1200
UON N

20196 grants / $241,960

The PRETEND Trial: A mixed methods study evaluating PREferences, feasibility, and costs of performing sham surgery Trials involving major surgical procedures$155,596

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Francesco Paolucci, Dr Samantha Bunzli, Professor Peter Choong, Associate Professor Michelle Dowsey, Professor Philip Clarke
Scheme Project Grant
Role Lead
Funding Start 2019
Funding Finish 2020
GNo G1900193
Type Of Funding C1100 - Aust Competitive - NHMRC
Category 1100
UON Y

University of Bologna and University of Newcastle$20,000

Funding body: Faculty of Business & Law, The University of Newcastle

Funding body Faculty of Business & Law, The University of Newcastle
Scheme International Research Collaboration Grant
Role Lead
Funding Start 2019
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

Aston University and University of Newcastle$20,000

Funding body: Faculty of Business & Law, The University of Newcastle

Funding body Faculty of Business & Law, The University of Newcastle
Project Team

Doctor Adrian Melia, Doctor Heidi Wechtler

Scheme International Research Collaboration Grant
Role Lead
Funding Start 2019
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

Gender Equality in the Medical Technology Industry$18,182

Funding body: Medical Technology Association of Australia

Funding body Medical Technology Association of Australia
Project Team Associate Professor Brendan Boyle, Associate Professor Caragh Brosnan, Professor Mark Flynn, Professor Rebecca Mitchell, Professor Francesco Paolucci
Scheme Research Grant
Role Investigator
Funding Start 2019
Funding Finish 2019
GNo G1900933
Type Of Funding C3100 – Aust For Profit
Category 3100
UON Y

nib Hospital Rate Inflation Project$18,182

Funding body: nib Health Funds Limited

Funding body nib Health Funds Limited
Project Team Professor Francesco Paolucci, Doctor Adrian Melia, Doctor Heidi Wechtler
Scheme Matched Industry Grant
Role Lead
Funding Start 2019
Funding Finish 2019
GNo G1901012
Type Of Funding C3100 – Aust For Profit
Category 3100
UON Y

Economic Development, Health and Nutrition for Sustainable Development $10,000

Funding body: Australia Africa Universities Network (AAUN)

Funding body Australia Africa Universities Network (AAUN)
Project Team Doctor Janet Dzator, Professor Francesco Paolucci, Doctor Adrian Melia, Doctor Heidi Wechtler, Prof. Yawe Bruno , Dr Allen Kabagenyi, Prof. Okurut Nathan, Prof Njoku Ama, James Gillespire, Dr Ekow Asmah, Dr Francis Andoh, Dr Michael Dzator
Scheme Partnership & Research Development Fund (PRDF)
Role Investigator
Funding Start 2019
Funding Finish 2020
GNo G1900649
Type Of Funding C3100 – Aust For Profit
Category 3100
UON Y

20181 grants / $9,000,000

ORTHOUNION$9,000,000

Funding body: European Commission, European Union

Funding body European Commission, European Union
Scheme Horizon 2020
Role Lead
Funding Start 2018
Funding Finish 2022
GNo
Type Of Funding International - Competitive
Category 3IFA
UON N

20175 grants / $12,860,924

Repurposing of carbamazepine for treatment of skeletal dysplasia$9,245,924

Funding body: European Commission, European Union

Funding body European Commission, European Union
Scheme Horizon 2020
Role Lead
Funding Start 2017
Funding Finish 2022
GNo
Type Of Funding International - Competitive
Category 3IFA
UON N

Patients First: the Continuous Improvement in Care - Cancer (The CIC Cancer Project)$3,500,000

Funding body: Cancer Research Trust

Funding body Cancer Research Trust
Project Team

Saunders C; Bellgrad M; Bulsara C; Bulsara M; Codde J; Ives A; Johnson C; McKenzie A; Micallef J; Platt V; Preen D; Reid C; Slavov-Azamonova N; Zeps N; Yeates A

Scheme Project Grant
Role Investigator
Funding Start 2017
Funding Finish 2022
GNo
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON N

Analysis of the economic and social impact of rare diseases on WA health system$50,000

Funding body: Western Australian Department of Health

Funding body Western Australian Department of Health
Scheme Project Grant
Role Lead
Funding Start 2017
Funding Finish 2017
GNo
Type Of Funding C2210 - Aust StateTerritoryLocal - Own Purpose
Category 2210
UON N

Evaluation of the potential impact of an ex-ante risk-equalisation model on the Australian PHI market$35,000

Funding body: Medibank Community Fund

Funding body Medibank Community Fund
Scheme Community Grants
Role Lead
Funding Start 2017
Funding Finish 2017
GNo
Type Of Funding C3111 - Aust For profit
Category 3111
UON N

Ishars impact on community health and wellbeing$30,000

Funding body: ISHAR

Funding body ISHAR
Scheme Ishar Exploratory Study
Role Lead
Funding Start 2017
Funding Finish 2017
GNo
Type Of Funding C3112 - Aust Not for profit
Category 3112
UON N

20162 grants / $50,100

Evaluation of Hospital Performance and costing modelling$50,000

Funding body: Saint John of God Healthcare

Funding body Saint John of God Healthcare
Scheme Project Grant
Role Lead
Funding Start 2016
Funding Finish 2016
GNo
Type Of Funding C3112 - Aust Not for profit
Category 3112
UON N

Support the Development and implementation of the WA Health Networks Action Plan$100

Funding body: Western Australian Department of Health

Funding body Western Australian Department of Health
Scheme Project Grant
Role Lead
Funding Start 2016
Funding Finish 2017
GNo
Type Of Funding C2210 - Aust StateTerritoryLocal - Own Purpose
Category 2210
UON N

20154 grants / $444,500

SCRIPT$300,000

Funding body: Murdoch University

Funding body Murdoch University
Scheme Divisional Research Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo
Type Of Funding Internal
Category INTE
UON N

Healthcare programs evaluation$113,000

Funding body: 360

Funding body 360
Scheme Project Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo
Type Of Funding C3112 - Aust Not for profit
Category 3112
UON N

Methicillin-resistant Staphylococcus ayrey$16,500

Funding body: Medical Research Foundation

Funding body Medical Research Foundation
Scheme Medical Research Foundation
Role Lead
Funding Start 2015
Funding Finish 2015
GNo
Type Of Funding C3112 - Aust Not for profit
Category 3112
UON N

Evaluation of the open borders programme$15,000

Funding body: Murdoch University

Funding body Murdoch University
Scheme Divisional Research Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo
Type Of Funding Internal
Category INTE
UON N

20142 grants / $107,000

Chronic care funding models by developing an economic conceptual framework and international case-studies on best practices in management of chronic conditions$100,000

Funding body: Victoria University

Funding body Victoria University
Scheme Grant
Role Lead
Funding Start 2014
Funding Finish 2015
GNo
Type Of Funding External
Category EXTE
UON N

School of Management Seed Grant Funding x2$7,000

Funding body: Murdoch University

Funding body Murdoch University
Scheme Divisional Research Grant
Role Lead
Funding Start 2014
Funding Finish 2015
GNo
Type Of Funding Internal
Category INTE
UON N

20131 grants / $30,000

Feasibility of risk-adjusted subsidies in Cambodia$30,000

Funding body: Micro Insurance Academy

Funding body Micro Insurance Academy
Scheme project grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo
Type Of Funding C3212 - International Not for profit
Category 3212
UON N

20121 grants / $30,000

Evaluation of the ex-post risk-equalisation mechanism$30,000

Funding body: Colombian Health Insurance Authority

Funding body Colombian Health Insurance Authority
Scheme project grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo
Type Of Funding C3232 - International Govt - Other
Category 3232
UON N

20111 grants / $40,000

The Design of Risk Adjustment in the Spanish Public Hospital Financing Scheme$40,000

Funding body: Universidad Complutense De Madrid

Funding body Universidad Complutense De Madrid
Scheme Visiting Scholar Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo
Type Of Funding Not Known
Category UNKN
UON N

20102 grants / $405,000

Time Scarcity in Australian families: another inequity?$325,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Scheme Collaborative Research Grant
Role Lead
Funding Start 2010
Funding Finish 2010
GNo
Type Of Funding Internal
Category INTE
UON N

Risk equalization techniques: an international comparison$80,000

Funding body: Murdoch University

Funding body Murdoch University
Scheme Divisional Research Grant
Role Lead
Funding Start 2010
Funding Finish 2010
GNo
Type Of Funding Internal
Category INTE
UON N

20091 grants / $100,000

The future of private health insurance in Australia: an economic analysis of (1) ‘Business-As-Usual’ and (2) ‘Medicare Select’ scenarios$100,000

Funding body: Medibank Community Fund

Funding body Medibank Community Fund
Scheme Community Grants
Role Lead
Funding Start 2009
Funding Finish 2009
GNo
Type Of Funding C3111 - Aust For profit
Category 3111
UON N
Edit

Research Supervision

Number of supervisions

Completed13
Current9

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2023 PhD Understanding the Drivers of Telehealth Usage among Patients in Australia and how it Reduces Costs over In-person Healthcare Services PhD (Health Economics), College of Human and Social Futures, The University of Newcastle Principal Supervisor
2022 PhD Strategic Framework for Private Health Insurance Purchasing in Australia PhD (Economics), College of Human and Social Futures, The University of Newcastle Principal Supervisor
2022 PhD Feasibility and Health Economics of Implementing Evidence-Based Prevention Interventions for Smoking Cessation in Pregnant Aboriginal Women into Primary Care Health Services PhD (Health Economics), College of Human and Social Futures, The University of Newcastle Principal Supervisor
2022 PhD Pathways to Reduce Maternal Mortality Ratios in Low and Middle-Income Countries by Identifying Factors Leading to Delays in Access to Maternal Care PhD (Reproductive Medicine), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2021 PhD Australian Health System - Risk Adjustment in Private Health Insurance PhD (Economics), College of Human and Social Futures, The University of Newcastle Principal Supervisor
2020 PhD Price Competition and Optimal Risk-Adjustment in Health Insurance Markets PhD (Economics), College of Human and Social Futures, The University of Newcastle Co-Supervisor
2020 PhD To What Extent are Hybrid Healthcare Systems Converging? Economic Analysis of the Implications of Hybridity on Health, Well-being and Performance PhD (Economics), College of Human and Social Futures, The University of Newcastle Principal Supervisor
2020 PhD Understanding Institutional and Regulatory Responses, Behaviors and Public Preferences and Decision-Making Trade-Offs of COVID-19 PhD (Health Economics), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2020 PhD Investigating Abnormal Financial Discounting Behaviour as a Way to Identify Potential Suicide Victims PhD (Economics), College of Human and Social Futures, The University of Newcastle Principal Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2021 Masters Justification on governments’ responses and their intensity against COVID-19 transmission. A comparative approach within Europe. Health Not Elswhere Classified, Management Center Innsbruck (MCI | The Entrepreneurial School®) Principal Supervisor
2021 Masters La Digital Health dopo il Covid- 19: disuguaglianze in salute e sistemi sanitari a confronto Other Health, University of Bologna Principal Supervisor
2020 Masters Comparative analysis of long-term care policies in the Netherlands and Chile Health Not Elswhere Classified, University of Bologna Principal Supervisor
2020 Masters On the implementation of a comprehensive HTA framework in Chile Health Not Elswhere Classified, University of Bologna Principal Supervisor
2020 Masters Macro and micro drivers of hospital inflation. Health Not Elswhere Classified, University of Bologna Principal Supervisor
2020 Masters Which preconditions must be fulfilled to achieve efficiency and affordability under Public-private mix based health systems? To what degree are they fulfilled?” - Case study of Australia Health Not Elswhere Classified, Management Center Innsbruck Principal Supervisor
2019 Masters Health Governance and Benefit Package Financing: Reform Proposal for the Chilean Economics, University of Bologna Principal Supervisor
2019 Masters The impact of voluntary deductibles in the Chilean health insurance market Economics, University of Bologna Principal Supervisor
2019 Masters Outpatient pharmaceutical insurance in the Chilean health insurance market Economics, University of Bologna Principal Supervisor
2019 Masters Risk rating in health insurance: A Tradeoff between efficiency and affordability or a means to reach both? Economics, University of Bologna Principal Supervisor
2019 Masters Cost-sharing in the private health insurance in Chile. Effects when premium rebates are either risk rated or community rated Economics, University of Bologna Principal Supervisor
2019 Masters The effects of risk equalization and risk sharing on private insurance risk rated premium Economics, University of Bologna Principal Supervisor
2015 PhD Micro health insurance in Bangladesh: prospects and challenges
https://openresearch-repository.anu.edu.au/handle/1885/106397
Economics, Australian National University Co-Supervisor
Edit

Research Projects

Preferences and trade-offs for dementia support programs features: A discrete choice experiment 2023 -

Dementia affects approximately 487,500 Australians (Dementia Australia 2022). Due to its profound adverse effects, dementia has been identified as the second leading cause of death in Australia. In 2020, dementia was the second leading cause of death in Australia, accounting for 14,500 deaths (or 9.6% of all deaths). The number of deaths due to dementia increased from 9,200 deaths in 2010 to 14,500 deaths in 2020. To support people with dementia in Australia, various organizations and initiatives have been established. These include support groups and online resources that aim to help people with dementia. However, little evidence exists about the public’s preferences for features of support interventions to support people with dementia. The aim of this study is to develop a survey to; understand the important factors for the public with reference to support interventions; provide insight into the value of different factors; and understand how respondents trade-off one factor against another.  

This study involves an online survey which will include a preference elicitation instrument called a discrete choice experiment (DCE). The DCE is informed by the literature review and expert opinions. The online survey will be open to the public in Australia who meet the inclusion criteria. Analysis of the survey data will allow us to quantify the value the public place on the different factors they consider when choosing support services for people with dementia and how those factors could be influenced to support people with dementia. 

Collaborators

Name Organisation
Professor Francesco Paolucci University of Newcastle

Edit

News

male and female sitting in a hospital waiting room wearing face masks

News • 8 Mar 2022

Study reveals the cycle of health inequity faced by migrants

While COVID-19 has affected everyone, the pandemic has exacerbated the vulnerability of migrants.

Image shows man standing facing the camera

News • 22 Feb 2022

The paradox of Australia’s response to COVID-19

A new report has found that the agile stability embedded in Australia’s health care state was ultimately responsible for the nation’s high vaccination rates.

News • 13 Oct 2020

Lessons Learnt: Special Issue report filters global best practices on COVID-19 response

A panel of experts have ‘filtered’ the most compelling policy and technology responses to COVID-19 worldwide, as governments continue to grapple with the devastating impacts of the pandemic.

researcher, Francesco, with view overlooking Newcastle city

News • 12 Oct 2020

Global discussion on the future of healthcare systems amid COVID-19

There is no doubt COVID-19 has burdened healthcare systems across the world but what can be learnt from this?

News • 29 Apr 2020

Newcastle Business School VheP group supporting the global fight on the covid-19 crisis

A faculty group from Newcastle Business School is exploring the impacts of COVID-19.

Professor Francesco Paolucci

Positions

Professor
Newcastle Business School
Newcastle Business School
College of Human and Social Futures

Casual Academic
Newcastle Business School
Newcastle Business School
College of Human and Social Futures

Focus area

Economics

Contact Details

Email francesco.paolucci@newcastle.edu.au
Phone +61 (2) 4921 5039
Links Twitter
Research Networks

Office

Room New Space Newcastle X-747
Building New Space Newcastle
Location Newcastle

,
Edit